Name: Staphylococcus aureus 209
Creator: BacDive
License: http://creativecommons.org/licenses/by-nc/4.0/

Strain identifier

BacDive ID: 14447

Type strain:

Species: Staphylococcus aureus

Strain Designation: 209

Culture col. no.: CCUG 10778, IFO 13276, CCM 4516, DSM 799, ATCC 6538, CIP 4.83, NCIMB 9518, NCTC 10788, WDCM 00032

Strain history: <- ATCC <- FDA, 209 <- AMC

NCBI tax ID(s): 1280 (species)

Other strains from Staphylococcus aureus

Section

Staphylococcus aureus 209 is a mesophilic human pathogen that was isolated from human lesion.

human pathogen
mesophilic
Bacteria
genome sequence

Information on the name and the taxonomic classification. Name and taxonomic classification

	Last LPSN update	25-08-2022 (DD-MM-YYYY)
	Domain	Bacteria
	Phylum	Bacillota
	Class	Bacilli
	Order	Caryophanales
	Family	Staphylococcaceae
	Genus	Staphylococcus
	Species	Staphylococcus aureus
	Full Scientific Name (PNU)	Staphylococcus aureus Rosenbach 1884 (Approved Lists 1980)

Synonym

Staphylococcus aureus subsp. anaerobius

Information on morphological and physiological properties Morphology

[Ref.: #455]	Type of hemolysis	beta
[Ref.: #455]	Incubation period	1-2 days

Information on culture and growth conditions Culture and growth conditions

[Ref.: #455]

Culture medium

COLUMBIA BLOOD MEDIUM (DSMZ Medium 693)

[Ref.: #455]

Culture medium growth

[Ref.: #455]

Culture medium link

Medium recipe at MediaDive

[Ref.: #455]

Culture medium composition

expand / minimize

[Ref.: #455]

Culture medium

TRYPTICASE SOY YEAST EXTRACT MEDIUM (DSMZ Medium 92)

[Ref.: #455]

Culture medium growth

[Ref.: #455]

Culture medium link

Medium recipe at MediaDive

[Ref.: #455]

Culture medium composition

expand / minimize

[Ref.: #41590]

Culture medium

MEDIUM 72- for trypto casein soja agar

[Ref.: #41590]

Culture medium growth

[Ref.: #41590]

Culture medium composition

expand / minimize

	Temperatures	Kind of temperature		Temperature
[Ref.: #455]			growth	37 °C
[Ref.: #41590]			growth	30 °C

[Ref.: #455]	Temperature range	mesophilic
[Ref.: #41590]	Temperature range	mesophilic

Information on physiology and metabolism Physiology and metabolism

Note that the displayed test results represent raw data and therefore may deviate!

Antibiotic susceptibility testing

Test 1

Test 2

Test 3

Test 4

Test 5

Test 6

Test 7

Test 8

Test 9

Test 10

Test 11

Test 12

Test 13

Test 14

Reference

[Ref.: #455]
Mueller-Hinton Agar



yes
Inhibition zone diameter in mm
48-50
40
46
50
40
46-48
48
32
resistant0
>50
34
32
26
26
22
32
32
30
28
resistant0
14
24
18
10
26
24
34-36
30-32
40
38-40
34
32
resistant0
30
20
38-40

[Ref.: #455]
Mueller-Hinton Agar



yes
Inhibition zone diameter in mm
48
38
42
50
38-40
46
42
32-34
resistant0
50
32-34
30-32
24
24
20
30
30
30
26
resistant0
12
24
18
10
34-36
20-22
34-36
32
36
40
34
30
resistant0
30
18
36-38

[Ref.: #455]
Mueller-Hinton Agar



yes
Inhibition zone diameter in mm
46
40
44-46
50
40
46-48
44
30-32
resistant0
>50
32-34
30
24
26-28
22
32-34
30
30
26
resistant0
12
24
18
10
26
20-22
32-34
32
36
34
32
30
resistant0
28-30
20
36-38

[Ref.: #455]
Mueller-Hinton Agar
37
1
aerob
yes
Inhibition zone diameter in mm
50
40
46
50
40
48-50
42-44
32-34
resistant0
>50
36
30
28
28
24
32-34
32
30-32
28
6-8
12
22
18
10
30
24
38-40
32-34
38-40
40
34-36
36-38
resistant0
30-32
20
40

[Ref.: #455]
Mueller-Hinton Agar
37
1
aerob
yes
Inhibition zone diameter in mm
50
40
46
50
40
50
44-46
36
resistant0
>50
40
32
26
26
22
32
30-32
30
26-28
resistant0
14
24
20
8-10
30
22-24
40
32-34
40
40
36
38
resistant0
30
20
38-40

[Ref.: #455]
Mueller-Hinton Agar
37


yes
Inhibition zone diameter in mm
32
26-28
30-32
36-38
30
32
30
22
resistant0
38-40
22
20
16-18
18
14
20
18-20
20-22
18
resistant0
8
16
12
6
18
14-16
12
n.d.
n.d.
n.d.
n.d.
n.d.
n.d.
n.d.
n.d.
n.d.

[Ref.: #455]
Mueller-Hinton Agar
37


yes
Inhibition zone diameter in mm
32
28-30
32
34
28-30
32-34
32
24
resistant0
38-40
22
20
16-18
16-18
14
20-22
18-20
22-24
20
resistant0
8
16
12
6
18-20
14
18-20
n.d.
n.d.
n.d.
n.d.
n.d.
n.d.
n.d.
n.d.
n.d.

[Ref.: #455]
Mueller-Hinton Agar
37


yes
Inhibition zone diameter in mm
36
28
30
38-40
28-30
32-34
32-34
20
resistant0
38-40
18-20
18
14
14
14
18-20
18
20
18-20
resistant0
10
18-20
10
6
16
16
20
n.d.
n.d.
n.d.
n.d.
n.d.
n.d.
n.d.
n.d.
n.d.

[Ref.: #455]
Mueller-Hinton Agar



yes
Inhibition zone diameter in mm
48
40
42-44
48
38
46-48
42-44
32-34
resistant0
50
32
30-32
24-26
26
20
30-32
30
30
28-30
resistant0
14
22
14-16
10
26
22
34
n.d.
n.d.
n.d.
n.d.
n.d.
n.d.
n.d.
n.d.
n.d.

[Ref.: #455]
Mueller-Hinton Agar
37


yes
Inhibition zone diameter in mm
48
38-40
44-46
>50
38
48
44
30-32
resistant0
>50
38-40
32-34
26-28
26-28
22
34
32
30-32
28-30
8
14
24
16-18
10
30
24
38
n.d.
n.d.
n.d.
n.d.
n.d.
n.d.
n.d.
n.d.
n.d.

[Ref.: #455]
Mueller-Hinton Agar
37


yes
Inhibition zone diameter in mm
44
36
42-44
48
36-38
44-46
42
32
resistant0
>50
34
30
28
26
22-24
32
30-32
30
26-28
6
16-18
24
16
10
28-30
22
26
n.d.
n.d.
n.d.
n.d.
n.d.
n.d.
n.d.
n.d.
n.d.

[Ref.: #455]
Mueller-Hinton Agar
37

aerob
yes
Inhibition zone diameter in mm
44
36
42
46-48
38-40
44
42
30-32
resistant0
50
32-34
30
24
26
28
30
30
30
28
resistant0
12
22
16
10
26
22-24
32-34
30
34
38-40
34
32
resistant0
28
20
34

[Ref.: #455]
Mueller-Hinton Agar
37

aerob
yes
Inhibition zone diameter in mm
44
36
42
46-48
38-40
44
42
30-32
resistant0
50
32-34
30
24
26
28
30
30
30
28
resistant0
12
22
16
10
26
22-24
32-34
30
34
38-40
34
32
resistant0
28
20
34

[Ref.: #455]
Mueller Hinton
37

aerob
yes
Inhibition zone diameter in mm
48
38
44
50
40
46
44
32
resistant0
>50
36
32
26
26
20-22
32
30
30
28
12
12
22-24
16
10
28
22
36
32
40
46
34
36
resistant0
30
20
40

Only first 15 entries are displayed. Click here to see all.

	Metabolite	Utilization activity	Kind of utilization tested
[Ref.: #68375]	arabinose ChEBI	-	fermentation	* from API ID32STA
[Ref.: #68378]	arginine ChEBI	+	hydrolysis	* from API STA, API ID32STA
[Ref.: #68375]	cellobiose ChEBI	-	fermentation	* from API ID32STA
[Ref.: #68378]	D-fructose ChEBI	+	builds acid from	* from API STA
[Ref.: #68375]	D-fructose ChEBI	+	fermentation	* from API ID32STA
[Ref.: #68375]	D-glucose ChEBI	+	fermentation	* from API ID32STA, API Coryne
[Ref.: #68378]	D-glucose ChEBI	-	builds acid from	* from API STA
[Ref.: #68378]	D-mannitol ChEBI	+	builds acid from	* from API STA
[Ref.: #68375]	D-mannitol ChEBI	+	fermentation	* from API ID32STA, API Coryne
[Ref.: #68378]	D-mannose ChEBI	+	builds acid from	* from API STA
[Ref.: #68375]	D-mannose ChEBI	+	fermentation	* from API ID32STA
[Ref.: #68379]	D-ribose ChEBI	+	fermentation	* from API Coryne
[Ref.: #68378]	D-xylose ChEBI	-	builds acid from	* from API STA
[Ref.: #68379]	D-xylose ChEBI	-	fermentation	* from API Coryne
[Ref.: #68379]	esculin ChEBI	+	hydrolysis	* from API Coryne
[Ref.: #68379]	gelatin ChEBI	+	hydrolysis	* from API Coryne
[Ref.: #68379]	glycogen ChEBI	-	fermentation	* from API Coryne
[Ref.: #68378]	lactose ChEBI	+	builds acid from	* from API STA
[Ref.: #68375]	lactose ChEBI	+	fermentation	* from API ID32STA, API Coryne
[Ref.: #68378]	maltose ChEBI	+	builds acid from	* from API STA
[Ref.: #68375]	maltose ChEBI	+	fermentation	* from API ID32STA, API Coryne
[Ref.: #68378]	melibiose ChEBI	-	builds acid from	* from API STA
[Ref.: #68378]	methyl alpha-D-glucopyranoside ChEBI	+	builds acid from	* from API STA
[Ref.: #68375]	N-acetylglucosamine ChEBI	+	fermentation	* from API ID32STA
[Ref.: #68378]	N-acetylglucosamine ChEBI	-	builds acid from	* from API STA
[Ref.: #68375]	nitrate ChEBI	+	reduction	* from API ID32STA, API Coryne
[Ref.: #68378]	nitrate ChEBI	-	reduction	* from API STA
[Ref.: #68375]	ornithine ChEBI	-	degradation	* from API ID32STA
[Ref.: #68378]	raffinose ChEBI	+	builds acid from	* from API STA
[Ref.: #68375]	raffinose ChEBI	-	fermentation	* from API ID32STA
[Ref.: #68375]	sucrose ChEBI	+	fermentation	* from API ID32STA, API Coryne
[Ref.: #68378]	sucrose ChEBI	-	builds acid from	* from API STA
[Ref.: #68378]	trehalose ChEBI	+	builds acid from	* from API STA
[Ref.: #68375]	trehalose ChEBI	+	fermentation	* from API ID32STA
[Ref.: #68375]	turanose ChEBI	-	fermentation	* from API ID32STA
[Ref.: #68378]	urea ChEBI	+	hydrolysis	* from API STA
[Ref.: #68379]	urea ChEBI	-	hydrolysis	* from API Coryne
[Ref.: #68378]	xylitol ChEBI	+	builds acid from	* from API STA
	Only first 10 entries are displayed. Click here to see all.

	Antibiotica	Metabolite	Antibiotic resistance
[Ref.: #68378]		lysostaphin	yes	* from API STA

	Metabolite production	Metabolite
[Ref.: #68378]		acetoin ChEBI	* from API STA

	Physiological tests	Metabolite	Voges-Proskauer-test
[Ref.: #68378]		acetoin ChEBI	+	* from API STA

	Enzyme	Enzyme activity	EC number
[Ref.: #68378]	alkaline phosphatase	+	3.1.3.1	* from API STA, API Coryne
[Ref.: #68379]	alpha-glucosidase	+	3.2.1.20	* from API Coryne
[Ref.: #68378]	arginine dihydrolase	+	3.5.3.6	* from API STA, API ID32STA
[Ref.: #68375]	beta-galactosidase	-	3.2.1.23	* from API ID32STA, API Coryne
[Ref.: #68379]	beta-glucosidase	+	3.2.1.21	* from API Coryne
[Ref.: #68375]	beta-glucuronidase	-	3.2.1.31	* from API ID32STA, API Coryne
[Ref.: #455]	catalase	+	1.11.1.6
[Ref.: #68379]	catalase	+	1.11.1.6	* from API Coryne
[Ref.: #455]	cytochrome-c oxidase	-	1.9.3.1
[Ref.: #68379]	gelatinase	+		* from API Coryne
[Ref.: #68375]	L-arginine arylamidase	-		* from API ID32STA
[Ref.: #68379]	N-acetyl-beta-glucosaminidase	-	3.2.1.52	* from API Coryne
[Ref.: #68375]	ornithine decarboxylase	-	4.1.1.17	* from API ID32STA
[Ref.: #68379]	pyrazinamidase	+	3.5.1.B15	* from API Coryne
[Ref.: #68379]	pyrrolidonyl arylamidase	+	3.4.19.3	* from API Coryne
[Ref.: #68378]	urease	+	3.5.1.5	* from API STA
[Ref.: #68379]	urease	-	3.5.1.5	* from API Coryne
	Only first 10 entries are displayed. Click here to see all.

Fatty acid profile

Metadata FA analysis

Reference

[Ref.: #45334]

Fatty acid	Percentage	ECL
C15:0 ANTEISO	63.9	14.711
C17:0 anteiso	15	16.722
C15:0 ISO	8	14.621
C17:0 iso	3.3	16.629
C18:2 ω6,9c/C18:0 ANTE	2.3	17.724
C19:0 ANTEISO	1.9	18.729
C18:0	1.5	18
C16:0	1.3	16
C16:0 iso	1	15.626
C14:0 ISO	0.7	13.618
C20:2 ω6,9c	0.6	19.735
Unidentified	0.4	13.248

API® Coryne:

Note that the displayed test results represent raw data and therefore may deviate!

	API ID	Reduction of nitrateNIT	PyrazinamidasePYZ	Pyrrolidonyl arylamidasePYRA	Alkaline phosphatasePAL	beta-Glucuronidasebeta GUR	beta-Galactosidasebeta GAL	alpha-Glucosidasealpha GLU	N-Acetyl-beta-Glucosidasebeta NAG	Esculin hydrolysis/beta-GlucosidaseESC	Urease/urea hydrolysisURE	Gelatinase/gelatin hydrolysisGEL	Control fermentationControl	Fermentation of D-glucoseGLU	Fermentation of D-riboseRIB	Fermentation of D-xyloseXYL	Fermentation of D-mannitolMAN	Fermentation of maltoseMAL	Fermentation of lactoseLAC	Fermentation of sucroseSAC	Fermentation of glycogenGLYG	CatalaseCAT
[Ref.: #45334]	2935	+	+	+	+	-	-	+	-	+	-	+	-	+	+	-	+	+	+	+	-	+

API® ID32STA:

Note that the displayed test results represent raw data and therefore may deviate!

	API ID	Urease/urea hydrolysisURE	Arginine dihydrolaseADH (Arg)	Ornithine decarboxylaseODC	Esculin hydrolysisESC	Fermentation of D-glucoseGLU	Fermentation of D-fructoseFRU	Fermentation of D-mannoseMNE	Fermentation of maltoseMAL	Fermentation of lactoseLAC	Fermentation of trehaloseTRE	Fermentation of D-mannitolMAN	Fermentation of raffinoseRAF	Fermentation of D-riboseRIB	Fermentation of cellobioseCEL	Reduction of nitrateNIT	Acetoin production (Voges Proskauer test)VP	beta-Galactosidasebeta GAL	L-arginine arylamidaseArgA	Alkaline phosphatasePAL	Pyrrolidonyl arylamidasePyrA	Novobiocin resistanceNOVO	Fermentation of sucroseSAC	Fermentation of N-acetyl-glucosamineNAG	Fermentation of turanoseTUR	Fermentation of arabinoseARA	beta-Glucuronidasebeta GUR
[Ref.: #455]	4472	+	+	-	-	+	+	+	+	+	+	+	-	-	-	+	+/-	-	-	+	+	+	+	+	-	-	-
[Ref.: #455]	4438	+	+	-	-	+	+	+	+	+	+	+	-	+	-	+	+	-	-	-	-	+	+	+	-	-	-
[Ref.: #45334]	1920	-	+	-	-	+	+	+	+	+	+	+	-	-	-	+	+	-	-	+	-	-	+	+	-	-	-
[Ref.: #455]	4004	+	+	-	-	+	+	+	+	+	+	+	-	+/-	-	+	+	-	-	+	-	-	+	+	-	-	-
[Ref.: #455]	4003	+	+	-	-	+	+	+	+	+	+	+	-	+	-	+	+	-	-	+	+/-	-	+	+	-	-	-
[Ref.: #455]	4002	+	+	-	-	+	+	+	+	+	+	+	-	+/-	-	+	+	-	-	+	-	+	+	+	-	-	-
[Ref.: #455]	4001	+	+	-	-	+	+	+	+	+	+	+	-	-	-	+	+	-	-	+	-	-	+	+	-	-	-
[Ref.: #455]	4000	+	+	-	+/-	+	+	+	+	+	+	+	-	-	-	+	+	-	-	+	-	+	+	+	-	-	-
[Ref.: #455]	3999	+	+	-	-	+	+	+	+	+	+	+	-	+	-	+	+	-	-	+	+	-	+	+	-	-	-
[Ref.: #455]	3998	+	+	-	-	+	+	+	+	+	+	+	-	+	-	+	+	-	-	+	+/-	-	+	+	-	-	-
[Ref.: #455]	3997	+	+	-	-	+	+	+	+	+	+	+	-	+	-	+	+	-	-	+	+	+	+	+	-	-	-
[Ref.: #455]	3996	+	+	-	-	+	+	+	+	+	+	+	-	+	-	+	+	-	-	+	+	-	+	+	-	-	-
[Ref.: #455]	3995	+	+	-	-	+	+	+	+	+	+	+	-	+	-	+	+	-	-	+	+	-	+	+	-	-	-
[Ref.: #455]	3994	+	+	-	-	+	+	+	+	+	+	+	-	+	-	+	+	-	-	+	+	+	+	+	-	-	-
[Ref.: #455]	4494	+	+	-	-	+	+	+	+	+	+	+	-	+	-	+	+	-	-	+	+	-	+	+	-	-	-
[Ref.: #455]	4503	-	+	-	-	+	+	+	+	+	+	+	-	-	-	+	+	-	-	+	+	-	+	+	-	-	-

API® STA:

Note that the displayed test results represent raw data and therefore may deviate!

	API ID	Control	Acid from D-glucoseGLU	Acid from D-fructoseFRU	Acid from D-mannoseMNE	Acid from maltoseMAL	Acid from lactoseLAC	Acid from trehaloseTRE	Acid from D-mannitolMAN	Acid from xylitolXLT	Acid from melibioseMEL	Reduction of nitrateNIT	Alkaline phosphatasePAL	Acetoin production (Voges Proskauer test)VP	Acid from raffinoseRAF	Acid from D-xyloseXYL	Acid from sucroseSAC	Acid from methyl-alpha-D-glucopyranosideMDG	Acid from N-acetyl-glucosamineNAG	Arginine dihydrolaseADH	Urease/urea hydrolysisURE	Resistance to lysostaphin (EC 3.4.24.75)LSTR
[Ref.: #45334]	9	not determinedn.d.	-	+	+	+	+	+	+	+	-	-	+	+	+	-	-	+	-	+	+	+

Information on isolation source, the sampling and environmental conditions Isolation, sampling and environmental information

[Ref.: #455]	Sample type/isolated from	human lesion

[Ref.: #45334]	Sample type/isolated from	Human lesion

Isolation sources categories

#Host	#Human	-
#Host Body-Site	#Other	#Wound
#Infection	#Patient	-

What are isolation sources categories?

Information on possible application of the strain and its possible interaction with e.g. potential hosts Safety information

[Ref.: #455]	Pathogenicity (human)	yes
[Ref.: #455]	Pathogenicity (animal)	yes
[Ref.: #455]	Biosafety level	2	Risk group (German classification) According to TRBA 466

Information on genomic background e.g. entries in nucleic sequence databass Sequence information

Genome sequence information:

Only first 5 entries are displayed. Click here to see all.

	Sequence accession description	Seq. accession number	Assembly level (bp)	Sequence database	Associated NCBI tax ID
[Ref.: #66792]	Staphylococcus aureus ATCC 6538	GCA_002025145	complete	GenBank	1280 tax ID	*
[Ref.: #66792]	Staphylococcus aureus NCTC10788	GCA_900457295	contig	GenBank	1280 tax ID	*
[Ref.: #66792]	Staphylococcus aureus DSM 799	GCA_000877975	contig	GenBank	1280 tax ID	*
[Ref.: #66792]	Staphylococcus aureus 209	GCA_002288945	scaffold	GenBank	1280 tax ID	*
[Ref.: #66792]	Staphylococcus aureus strain NCTC10788	1280.18032	wgs	PATRIC	1280 tax ID	*
[Ref.: #66792]	Staphylococcus aureus subsp. aureus strain ATCC 6538	46170.458	plasmid	PATRIC	1280 tax ID	*

Availability in culture collections External links

[Ref.: #455]

Culture collection no.

CCUG 10778, IFO 13276, CCM 4516, DSM 799, ATCC 6538, CIP 4.83, NCIMB 9518, NCTC 10788, WDCM 00032

[Ref.: #20218]

Associated Passport(s) in StrainInfo

53789, 230328, 155230, 53797, 866262

Literature:

Only first 10 entries are displayed. Click here to see all.

Topic	Title	Authors	Journal	DOI	Year
Pathogenicity	A reliable two-hour Staphylococcus plate assay of rifampicin, erythromycin, lincomycin, chloramphenicol and amikacin in human sera.	Fanaki NH, el-Nakeeb MA	J Chemother	10.1080/1120009x.1991.11739111	1991	*
Cultivation	[Growth of Staphylococcus aureus in solid media with a water activity less than 0.86].	Giannuzzi L, Parada JL	Rev Argent Microbiol		1991	*
Pathogenicity	[Microbiological evaluation of chemical disinfectants for household use].	Timenetsky J	Rev Saude Publica	10.1590/s0034-89101990000100008	1990	*
Pathogenicity	Disinfection with gaseous formaldehyde. Second Part: Influence of test materials on formaldehyde residues and the bactericidal and sporicidal effectiveness.	Casella ML, Schmidt-Lorenz W	Zentralbl Hyg Umweltmed		1989	*
Pathogenicity	Disinfection with gaseous formaldehyde. Third Part: Bactericidal and sporicidal effectiveness of gaseous formaldehyde and level of residues in dependence on concentration, temperature and relative humidity.	Casella ML, Schmidt-Lorenz W	Zentralbl Hyg Umweltmed		1989	*
Pathogenicity	Disinfection with gaseous formaldehyde. Fifth Part: Influence of albumin, mucin and blood on the bactericidal and sporicidal effectiveness.	Casella ML, Schmidt-Lorenz W	Zentralbl Hyg Umweltmed		1989	*
Pathogenicity	[Phenolic coefficient in the microbiological evaluation of disinfectants for hospital and household use].	Timenetsky J, Alterthum F	Rev Saude Publica	10.1590/s0034-89101989000200011	1989	*
Pathogenicity	Disinfection with gaseous formaldehyde. First Part: Bactericidal and sporicidal effectiveness of formaldehyde with and without formation of a condensing layer.	Casella ML, Schmidt-Lorenz W	Zentralbl Hyg Umweltmed		1989	*
Pathogenicity	Disinfectant properties of new povidone-iodine preparations.	Schubert R	J Hosp Infect	10.1016/s0195-6701(85)80043-8	1985	*
Metabolism	In vitro bactericidal activity of sulbactam plus ampicillin against methicillin-resistant Staphylococcus aureus.	Kazmierczak A, Duez JM, Pechinot A, Nordmann P, Labia R	Rev Infect Dis	10.1093/clinids/8.supplement_5.s549	1986	*
Pathogenicity	Ineffectiveness of hospital disinfectants against bacteria: a collaborative study.	Rutala WA, Cole EC	Infect Control	10.1017/s0195941700067564	1987	*
Pathogenicity	Effects of Freon-113 on the survival of bacteria.	Sousa S, Akkara JA, Kaplan DL	J Appl Bacteriol	10.1111/j.1365-2672.1987.tb02727.x	1987	*
Cultivation	Standardization of bacterial numbers of penicylinders used in disinfectant testing: interlaboratory study.	Cole EC, Rutala WA, Samsa GP	J Assoc Off Anal Chem		1987	*
Enzymology	Potentially infectious agents associated with shearling bedpads: effect of laundering with detergent-disinfectant combinations on Staphylococcus aureus and Pseudomonas aeruginosa.	Wilkoff LJ, Dixon GJ, Westbrook L, Happich WF	Appl Microbiol	10.1128/am.21.4.647-652.1971	1971	*
Pathogenicity	Administration of antibiotics in combination. The antibacterial activity of blood serum and urine after a simultaneous administration of aminoglycosides and ampicillin.	Janovska D, Vymola F, Godova T	J Hyg Epidemiol Microbiol Immunol		1984	*
Pathogenicity	Structural changes induced by subinhibitory concentrations of fosfomycin on Staphylococcus aureus and Bacillus cereus.	Carlone NA, Cuffini AM, Cattaneo O	Microbios		1982	*
Enzymology	Methodology for recovery of chemically treated Staphylococcus aureus with neutralizing medium.	Dey BP, Engley FB Jr	Appl Environ Microbiol	10.1128/aem.45.5.1533-1537.1983	1983	*
Cultivation	Comparison of Dey and Engley (D/E) neutralizing medium to Letheen medium and standard methods medium for recovery of Staphylococcus aureus from sanitized surfaces.	Dey BP, Engley FB Jr	J Ind Microbiol	10.1007/BF01570061	1995	*
Pathogenicity	Activity of aztreonam in pneumology, Part 2: Influence on phagocytosis and intracellular killing of human alveolar macrophages.	Velluti G, Garuti GC, Bonucchi ME, Gilioli F, Capelli O, Rovatti E, Covi M	J Chemother	10.1080/1120009x.1994.11741128	1994	*
Pathogenicity	Iron repressibility of siderophore and transferrin-binding protein in Staphylococcus aureus.	Lim Y, Shin SH, Lee SI, Kim IS, Rhee JH	FEMS Microbiol Lett	10.1111/j.1574-6968.1998.tb13020.x	1998	*
Metabolism	A human transferrin-binding protein of Staphylococcus aureus is immunogenic in vivo and has an epitope in common with human transferrin receptor.	Lim Y, Shin SH, Jang IY, Rhee JH, Kim IS	FEMS Microbiol Lett	10.1111/j.1574-6968.1998.tb13894.x	1998	*
Pathogenicity	Synthesis and evaluation of lysozyme derivatives exhibiting an enhanced antimicrobial action.	Bernkop-Schnurch A, Krist S, Vehabovic M, Valenta C	Eur J Pharm Sci	10.1016/s0928-0987(97)10026-4	1998	*
Pathogenicity	Susceptibility of antibiotic-resistant and antibiotic-sensitive foodborne pathogens to acid anionic sanitizers.	Lopes JA	J Food Prot	10.4315/0362-028x-61.10.1390	1998	*
Pathogenicity	Factors influencing a suspension test method for antimicrobial activity of disinfectants.	Langsrud S, Sundheim G	J Appl Microbiol	10.1111/j.1365-2672.1998.tb05265.x	1998	*
Pathogenicity	[Investigation and identification of the antimicrobial component of the drug "Tomatol"].	Vorob'ev AA, Seleznev AS, Pavlova LA, Iang A, Ershova NN	Antibiot Khimioter		1999	*
Pathogenicity	Combination of hydrostatic pressure and lacticin 3147 causes increased killing of Staphylococcus and Listeria.	Morgan SM, Ross RP, Beresford T, Hill C	J Appl Microbiol	10.1046/j.1365-2672.2000.00975.x	2000	*
Pathogenicity	Synthesis and antimicrobial activity of 4-carbethoxymethyl-2-[(alpha-haloacyl)amino] thiazoles and 5-nonsubstituted/substituted 2-[(4-carbethoxymethylthiazol-2-yl)imino]-4-thiazolidinones.	Ates O, Altintas H, Otuk G	Arzneimittelforschung	10.1055/s-0031-1300251	2000	*
Pathogenicity	Behavior of enterotoxigenic strains of Staphylococcus aureus in milk fermented with a yogurt starter culture.	Zuniga Estrada A, Sanchez Mendoza M, Mota de la Garza L, Ortigoza Ferado J	Rev Latinoam Microbiol		1999	*
Biotechnology	Use of hydrostatic pressure for inactivation of microbial contaminants in cheese.	O'Reilly CE, O'Connor PM, Kelly AL, Beresford TP, Murphy PM	Appl Environ Microbiol	10.1128/AEM.66.11.4890-4896.2000	2000	*
Pathogenicity	Synthesis and antimicrobial activity of new 6-phenylimidazo[2,1-b]thiazole derivatives.	Ulusoy N, Capan G, Otuk G, Kiraz M	Boll Chim Farm		2000	*
Pathogenicity	Lactic acid bacteria from healthy oral cavity of Thai volunteers: inhibition of oral pathogens.	Sookkhee S, Chulasiri M, Prachyabrued W	J Appl Microbiol	10.1046/j.1365-2672.2001.01229.x	2001	*
Pathogenicity	Antimicrobial and chemical study of MTA, Portland cement, calcium hydroxide paste, Sealapex and Dycal.	Estrela C, Bammann LL, Estrela CR, Silva RS, Pecora JD	Braz Dent J		2000	*
Pathogenicity	Synthesis of Mannich bases of some 2,5-disubstituted 4-thiazolidinones and evaluation of their antimicrobial activities.	Kocabalkanli A, Ates O, Otuk G	Arch Pharm (Weinheim)	10.1002/1521-4184(200102)334:2<35::aid-ardp35>3.0.co;2-4	2001	*
Pathogenicity	Antibacterial diterpenes from the roots of Salvia blepharochlaena.	Ulubelen A, Oksuz S, Topcu G, Goren AC, Voelter W	J Nat Prod	10.1021/np0004956	2001	*
Pathogenicity	Two methods to evaluate the antimicrobial action of calcium hydroxide paste.	Estrela C, Rodrigues de Araujo Estrela C, Bammann LL, Pecora JD	J Endod	10.1097/00004770-200112000-00002	2001	*
Pathogenicity	Synthesis of some 4-(alkylidene/arylidene)amino-2,4-dihydro-5- (2-thienyl)-3H-1,2,4-triazole-3-thiones tested for antimicrobial activity.	Ulusoy N, Ergenc N, Otuk G, Kiraz M	Boll Chim Farm		2001	*
Pathogenicity	Synthesis and antimicrobial activity of some 1,2,4-triazole-3-mercaptoacetic acid derivatives.	Ulusoy N, Gursoy A, Otuk G	Farmaco	10.1016/s0014-827x(01)01128-4	2001	*
Pathogenicity	Synthesis and evaluation of antibacterial activity of some 2-[[alpha-(4-substituted benzoyloxy)-alpha-phenylacetyl or methylacetyl]amino]-5-(4-methoxyphenyl)- 1,3,4-oxadiazoles.	Kocabalkanli A, Ates O, Otuk G	Farmaco	10.1016/s0014-827x(01)01158-2	2001	*
Pathogenicity	Bactericidal capability of blood platelets in eutrophic newborns.	Bialowas D, Kemona H, Prokopowicz J	Haematologia (Budap)		1995	*
Metabolism	[In vitro evaluation of antibacterial substances produced by bacteria isolated from different marine organisms].	Castillo I, Lodeiros C, Nunez M, Campos I	Rev Biol Trop		2001	*
Biotechnology	Barotolerance of Staphylococcus aureus is increased by incubation at below 0 degrees C prior to hydrostatic pressure treatment.	Noma S, Hayakawa I	Int J Food Microbiol	10.1016/s0168-1605(02)00142-3	2003	*
Pathogenicity	Synthesis and antimicrobial activity of [2-[2-(N, N-disubstituted thiocarbamoyl-sulfanyl)-acylamino] thiazol-4-yl]acetic acid ethyl esters.	Ates O, Gursoy A, Altintas H, Otuk G, Birteksoz S	Arch Pharm (Weinheim)	10.1002/ardp.200390002	2003	*
Pathogenicity	Growth and siderophore production of staphylococci in human peritoneal dialysate.	Chung JH, Park MH, Kim JH, Lim Y, Shin SH	J Korean Med Sci	10.3346/jkms.2003.18.2.158	2003	*
Pathogenicity	Comparison of micellar electrokinetic chromatography, liquid chromatography, and microbiologic assay for analysis of cephalexin in oral suspensions.	Steppe M, Aurora Prado MS, Tavares MF, Pinto TJ, Kedor-Hackmann ER, Santoro MI	J AOAC Int		2003	*
Metabolism	Development of a screening assay to measure the loss of antibacterial activity in the presence of proteins: its use in optimizing compound structure.	Roychoudhury S, Brill JL, Lu WP, White RE, Chen Z, Demuth TP Jr	J Biomol Screen	10.1177/1087057103256917	2003	*
Pathogenicity	Synthesis of some new 6-methylimidazo[2,1-b]thiazole-5-carbohydrazide derivatives and their antimicrobial activities.	Ur F, Cesur N, Birteksoz S, Otuk G	Arzneimittelforschung	10.1055/s-0031-1296947	2004	*
Pathogenicity	The effects of chlorhexidine gluconate (0.12%) on the antimicrobial properties of tooth-colored ProRoot mineral trioxide aggregate.	Stowe TJ, Sedgley CM, Stowe B, Fenno JC	J Endod	10.1097/00004770-200406000-00013	2004	*
Pathogenicity	[Study on the resistance of methicillin-resistant staphylococcus aureus to iodophor and chlorhexidine].	Zhang YH, Liu XY, Zhu LL, Yu YZ	Zhonghua Liu Xing Bing Xue Za Zhi		2004	*
Metabolism	Bacterial growth in amniotic fluid is dependent on the iron-availability and the activity of bacterial iron-uptake system.	Ahn YJ, Park SK, Oh JW, Sun HY, Shin SH	J Korean Med Sci	10.3346/jkms.2004.19.3.333	2004	*
Pathogenicity	[Efficacy of biocides against hospital isolates of Staphylococcus sensitive and resistant to methicillin, in the province of Buenos Aires, Argentina].	Reynaldo MB, Flores MB, Viegas Caetano JA, Magarinos Mdel C	Rev Panam Salud Publica	10.1590/s1020-49892004000900005	2004	*
Pathogenicity	Allylthiosulfinate: beta-cyclodextrin inclusion complex: preparation, characterization and microbiological activity.	Nikolic V, Stankovic M, Kapor A, Nikolic Lj, Cvetkovic D, Stamenkovic J	Pharmazie		2004	*
Pathogenicity	Essential oils of Satureja, Origanum, and Thymus species: chemical composition and antibacterial activities against foodborne pathogens.	Chorianopoulos N, Kalpoutzakis E, Aligiannis N, Mitaku S, Nychas GJ, Haroutounian SA	J Agric Food Chem	10.1021/jf049113i	2004	*
Pathogenicity	The killing effect of cryptolepine on Staphylococcus aureus.	Sawer IK, Berry MI, Ford JL	Lett Appl Microbiol	10.1111/j.1472-765X.2004.01625.x	2005	*
Pathogenicity	Synthesis and antibacterial activity of 4-benzoyl-1-methyl-5-phenyl-1H-pyrazole-3-carboxylic acid and derivatives.	Akbas E, Berber I, Sener A, Hasanov B	Farmaco	10.1016/j.farmac.2004.09.003	2004	*
Pathogenicity	Growth of Staphylococcus aureus with defective siderophore production in human peritoneal dialysate solution.	Park RY, Sun HY, Choi MH, Bae YH, Shin SH	J Microbiol	2137	2005	*
Pathogenicity	Antibacterial screening of anthocyanic and proanthocyanic fractions from cranberry juice.	Leitao DP, Polizello AC, Ito IY, Spadaro AC	J Med Food	10.1089/jmf.2005.8.36	2005	*
Biotechnology	Inactivation of Staphylococcus aureus and Salmonella enteritidis in tryptic soy broth and caviar samples by high pressure processing.	Fioretto F, Cruz C, Largeteau A, Sarli TA, Demazeau G, El Moueffak A	Braz J Med Biol Res	10.1590/s0100-879x2005000800015	2005	*
Pathogenicity	Synthesis and antimicrobial activity of some novel derivatives of benzofuran: part 1. Synthesis and antimicrobial activity of (benzofuran-2-yl)(3-phenyl-3-methylcyclobutyl) ketoxime derivatives.	Koca M, Servi S, Kirilmis C, Ahmedzade M, Kazaz C, Ozbek B, Otuk G	Eur J Med Chem	10.1016/j.ejmech.2005.07.004	2005	*
Pathogenicity	Comparative mutant prevention concentrations of pradofloxacin and other veterinary fluoroquinolones indicate differing potentials in preventing selection of resistance.	Wetzstein HG	Antimicrob Agents Chemother	10.1128/AAC.49.10.4166-4173.2005	2005	*
Pathogenicity	Synthesis, antibacterial and antifungal activity of some new pyridazinone metal complexes.	Sonmez M, Berber I, Akbas E	Eur J Med Chem	10.1016/j.ejmech.2005.10.003	2005	*
Pathogenicity	Antimicrobial preservative effectiveness of natural peptide antibiotics.	Kamysz W, Turecka K	Acta Pol Pharm		2005	*
Pathogenicity	Long-chain 3-acyl-4-hydroxycoumarins: structure and antibacterial activity.	Cravotto G, Tagliapietra S, Cappello R, Palmisano G, Curini M, Boccalini M	Arch Pharm (Weinheim)	10.1002/ardp.200500127	2006	*
Pathogenicity	Synthesis and evaluation of antimicrobial and anticonvulsant activities of some new 3-[2- (5-aryl-1,3,4-oxadiazol-2-yl/4-carbethoxymethylthiazol-2-yl) imino-4-thiazolidinon-5-ylidene]-5-substituted/nonsubstituted 1H-indole-2-ones and investigation of their structure-activity relationships.	Altintas H, Ates O, Uyde-Dogan BS, Alp FI, Kaleli D, Ozdemir O, Birteksoz S, Otuk G, Atana D, Uzun M	Arzneimittelforschung		2006	*
Pathogenicity	Antibacterial activity of bioconverted eicosapentaenoic (EPA) and docosahexaenoic acid (DHA) against foodborne pathogenic bacteria.	Shin SY, Bajpai VK, Kim HR, Kang SC	Int J Food Microbiol	10.1016/j.ijfoodmicro.2006.05.020	2006	*
Pathogenicity	[Microbiological assessment of efficiency of antibacterial modified textiles].	Jakimiak B, Rohm-Rodowald E, Staniszewska M, Cieslak M, Malinowska G, Kaleta A	Rocz Panstw Zakl Hig		2006	*
Pathogenicity	Antibacterial effect of some essential oils administered alone or in combination with Norfloxacin.	Rosato A, Vitali C, De Laurentis N, Armenise D, Antonietta Milillo M	Phytomedicine	10.1016/j.phymed.2007.01.005	2007	*
Pathogenicity	Antibacterial activity of plastics coated with silver-doped organic-inorganic hybrid coatings prepared by sol-gel processes.	Marini M, De Niederhausern S, Iseppi R, Bondi M, Sabia C, Toselli M, Pilati F	Biomacromolecules	10.1021/bm060721b	2007	*
Pathogenicity	In vitro antimicrobial activity of different gutta-percha points and calcium hydroxide pastes.	Tanomaru JM, Pappen FG, Tanomaru Filho M, Spolidorio DM, Ito IY	Braz Oral Res	10.1590/s1806-83242007000100006	2007	*
Pathogenicity	In vitro antimicrobial activity of endodontic sealers, MTA-based cements and Portland cement.	Tanomaru-Filho M, Tanomaru JM, Barros DB, Watanabe E, Ito IY	J Oral Sci	10.2334/josnusd.49.41	2007	*
Pathogenicity	Synthesis and antimicrobial activity of some novel derivatives of benzofuran: part 2. The synthesis and antimicrobial activity of some novel 1-(1-benzofuran-2-yl)-2-mesitylethanone derivatives.	Kirilmis C, Ahmedzade M, Servi S, Koca M, Kizirgil A, Kazaz C	Eur J Med Chem	10.1016/j.ejmech.2007.03.023	2007	*
Enzymology	[Cloning and expression of the nickel/cobalt transferase gene in E. coli BL21 and bioaccumulation of nickel ion by genetically engineered strain].	Zhang YM, Yin H, Ye JS, Peng H, Zhang N, Qin HM, Yang F, He BY	Huan Jing Ke Xue		2007	*
Enzymology	Bioactive p-terphenyl derivatives from a Cordyceps-colonizing isolate of Gliocladium sp.	Guo H, Hu H, Liu S, Liu X, Zhou Y, Che Y	J Nat Prod	10.1021/np070231k	2007	*
Pathogenicity	Novel lipid and preservative-free propofol formulation: properties and pharmacodynamics.	Ravenelle F, Gori S, Le Garrec D, Lessard D, Luo L, Palusova D, Sneyd JR, Smith D	Pharm Res	10.1007/s11095-007-9471-5	2007	*
Pathogenicity	Enamines as novel antibacterials and their structure-activity relationships.	Xiao ZP, Fang RQ, Li HQ, Xue JY, Zheng Y, Zhu HL	Eur J Med Chem	10.1016/j.ejmech.2007.11.026	2007	*
Pathogenicity	Inactivation of bacterial pathogens in human milk by high-pressure processing.	Viazis S, Farkas BE, Jaykus LA	J Food Prot	10.4315/0362-028x-71.1.109	2008	*
Enzymology	Enrichment of fluoroquinolone-resistant Staphylococcus aureus: oscillating ciprofloxacin concentrations simulated at the upper and lower portions of the mutant selection window.	Firsov AA, Lubenko IY, Smirnova MV, Strukova EN, Zinner SH	Antimicrob Agents Chemother	10.1128/AAC.01371-07	2008	*
Pathogenicity	Synthesis, characterization and structure-activity relationship analysis of novel depsides as potential antibacterials.	Lv PC, Xiao ZP, Fang RQ, Li HQ, Zhu HL, Liu CH	Eur J Med Chem	10.1016/j.ejmech.2008.04.019	2008	*
Pathogenicity	Chemical composition and inhibitory parameters of essential oil and extracts of Nandina domestica Thunb. to control food-borne pathogenic and spoilage bacteria.	Bajpai VK, Rahman A, Kang SC	Int J Food Microbiol	10.1016/j.ijfoodmicro.2008.03.011	2008	*
Pathogenicity	Coagulation property of hyaluronic acid-collagen/chitosan complex film.	Wu Y, Hu Y, Cai J, Ma S, Wang X	J Mater Sci Mater Med	10.1007/s10856-008-3477-3	2008	*
Enzymology	Enrichment of resistant Staphylococcus aureus at ciprofloxacin concentrations simulated within the mutant selection window: bolus versus continuous infusion.	Firsov AA, Smirnova MV, Strukova EN, Vostrov SN, Portnoy YA, Zinner SH	Int J Antimicrob Agents	10.1016/j.ijantimicag.2008.06.031	2008	*
Pathogenicity	Bacteriostasis testing on allograft tissue inoculated in Wilkins-Chalgren broth.	Saegeman V, Ectors N, Lismont D, Verduyckt B, Verhaegen J	J Hosp Infect	10.1016/j.jhin.2008.07.020	2008	*
Pathogenicity	Bactericidal properties of ZnO-Al(2)O (3) composites formed from layered double hydroxide precursors.	Lin YJ, Xu XY, Huang L, Evans DG, Li DQ	J Mater Sci Mater Med	10.1007/s10856-008-3585-0	2008	*
Pathogenicity	Electrospun polyacrylonitrile nanofibrous biomaterials.	Ren X, Akdag A, Zhu C, Kou L, Worley SD, Huang TS	J Biomed Mater Res A	10.1002/jbm.a.32260	2009	*
Pathogenicity	Antimicrobial activity of endodontic sealers based on calcium hydroxide and MTA.	Tanomaru JM, Tanomaru-Filho M, Hotta J, Watanabe E, Ito IY	Acta Odontol Latinoam		2008	*
Pathogenicity	Synthesis, structure and structure-activity relationship analysis of 3-tert-butoxycarbonyl-2-arylthiazolidine-4-carboxylic acid derivatives as potential antibacterial agents.	Song ZC, Ma GY, Lv PC, Li HQ, Xiao ZP, Zhu HL	Eur J Med Chem	10.1016/j.ejmech.2009.04.014	2009	*
Pathogenicity	Antimicrobial activity of lavender, tea tree and lemon oils in cosmetic preservative systems.	Kunicka-Styczynska A, Sikora M, Kalemba D	J Appl Microbiol	10.1111/j.1365-2672.2009.04372.x	2009	*
Pathogenicity	Tocopherol, carotene, phenolic contents and antibacterial properties of rose essential oil, hydrosol and absolute.	Ulusoy S, Bosgelmez-Tinaz G, Secilmis-Canbay H	Curr Microbiol	10.1007/s00284-009-9475-y	2009	*
Pathogenicity	Chemical composition and antibacterial activity of the essential oil of Cordia verbenacea from the Venezuelan Andes.	Meccia G, Rojas LB, Velasco J, Diaz T, Usubillaga A, Arzola JC, Ramos S	Nat Prod Commun		2009	*
Pathogenicity	Synergistic interaction of Helichrysum pedunculatum leaf extracts with antibiotics against wound infection associated bacteria.	Aiyegoro OA, Afolayan AJ, Okoh AI	Biol Res	/S0716-97602009000300007	2009	*
Pathogenicity	[Characterization of batumin resistant variants of Staphylococcus aureus clinical isolates].	Churkina LN, Bidnenko SI, Avdeeva LV, Iaroshenko LV	Antibiot Khimioter		2009	*
Enzymology	Evaluation of the decontamination efficacy of new and reprocessed microfiber cleaning cloth compared with other commonly used cleaning cloths in the hospital.	Diab-Elschahawi M, Assadian O, Blacky A, Stadler M, Pernicka E, Berger J, Resch H, Koller W	Am J Infect Control	10.1016/j.ajic.2009.09.006	2010	*
Pathogenicity	Staphylococcal strains adapted to epigallocathechin gallate (EGCG) show reduced susceptibility to vancomycin, oxacillin and ampicillin, increased heat tolerance, and altered cell morphology.	Bikels-Goshen T, Landau E, Saguy S, Shapira R	Int J Food Microbiol	10.1016/j.ijfoodmicro.2010.01.011	2010	*
Pathogenicity	Synthesis, spectroscopic and biological studies on the new symmetric Schiff base derived from 2,6-diformyl-4-methylphenol with N-aminopyrimidine.	Sonmez M, Celebi M, Berber I	Eur J Med Chem	10.1016/j.ejmech.2010.01.035	2010	*
Pathogenicity	Novel depsides as potential anti-inflammatory agents with potent inhibitory activity against Escherichia coli-induced interleukin-8 production.	Lv PC, Xiong J, Chen J, Wang KR, Mao WJ, Zhu HL	J Enzyme Inhib Med Chem	10.3109/14756360903357551	2010	*
Pathogenicity	Antimicrobial and antioxidant activities of Mexican oregano essential oils (Lippia graveolens H. B. K.) with different composition when microencapsulated in beta-cyclodextrin.	Arana-Sanchez A, Estarron-Espinosa M, Obledo-Vazquez EN, Padilla-Camberos E, Silva-Vazquez R, Lugo-Cervantes E	Lett Appl Microbiol	10.1111/j.1472-765X.2010.02837.x	2010	*
Pathogenicity	The role of bioactive substances in controlling foodborne pathogens derived from Metasequoia glyptostroboides Miki ex Hu.	Bajpai VK, Na M, Kang SC	Food Chem Toxicol	10.1016/j.fct.2010.04.041	2010	*
Pathogenicity	P(4-VP) based nanoparticles and composites with dual action as antimicrobial materials.	Ozay O, Akcali A, Otkun MT, Silan C, Aktas N, Sahiner N	Colloids Surf B Biointerfaces	10.1016/j.colsurfb.2010.05.013	2010	*
Pathogenicity	Removal of biofilm from contact lens storage cases.	Wu YT, Zhu H, Willcox M, Stapleton F	Invest Ophthalmol Vis Sci	10.1167/iovs.10-5796	2010	*
Pathogenicity	Bactericidal effects of non-thermal argon plasma in vitro, in biofilms and in the animal model of infected wounds.	Ermolaeva SA, Varfolomeev AF, Chernukha MY, Yurov DS, Vasiliev MM, Kaminskaya AA, Moisenovich MM, Romanova JM, Murashev AN, Selezneva II, Shimizu T, Sysolyatina EV, Shaginyan IA, Petrov OF, Mayevsky EI, Fortov VE, Morfill GE, Naroditsky BS, Gintsburg AL	J Med Microbiol	10.1099/jmm.0.020263-0	2010	*
Pathogenicity	Evaluation of an innovative antimicrobial surgical glove technology to reduce the risk of microbial passage following intraoperative perforation.	Daeschlein G, Kramer A, Arnold A, Ladwig A, Seabrook GR, Edmiston CE Jr	Am J Infect Control	10.1016/j.ajic.2010.05.026	2011	*
Pathogenicity	Antibacterial abietane-type diterpenoid, taxodone from Metasequoia glyptostroboides Miki ex Hu.	Bajpai VK, Kang SC	J Biosci	10.1007/s12038-010-0061-z	2010	*
Pathogenicity	Environmentally friendly antibacterial cotton textiles finished with siloxane sulfopropylbetaine.	Chen S, Chen S, Jiang S, Xiong M, Luo J, Tang J, Ge Z	ACS Appl Mater Interfaces	10.1021/am101275d	2011	*
Pathogenicity	Synthesis, antibacterial and antifungal activities of bifonazole derivatives.	El Hage S, Lajoie B, Feuillolay C, Roques C, Baziard G	Arch Pharm (Weinheim)	10.1002/ardp.201000304	2011	*
Pathogenicity	Study of zwitterionic sulfopropylbetaine containing reactive siloxanes for application in antibacterial materials.	Chen S, Chen S, Jiang S, Mo Y, Luo J, Tang J, Ge Z	Colloids Surf B Biointerfaces	10.1016/j.colsurfb.2011.03.004	2011	*
Pathogenicity	Antimicrobial properties of stem bark extracts from Phyllanthus muellerianus (Kuntze) Excell.	Brusotti G, Cesari I, Frassa G, Grisoli P, Dacarro C, Caccialanza G	J Ethnopharmacol	10.1016/j.jep.2011.03.042	2011	*
Pathogenicity	The effectiveness of various cleaning regimens and current guidelines in contact lens case biofilm removal.	Wu YT, Zhu H, Willcox M, Stapleton F	Invest Ophthalmol Vis Sci	10.1167/iovs.10-6785	2011	*
Pathogenicity	Importance of rub and rinse in use of multipurpose contact lens solution.	Zhu H, Bandara MB, Vijay AK, Masoudi S, Wu D, Willcox MD	Optom Vis Sci	10.1097/OPX.0b013e31821bf976	2011	*
Pathogenicity	In vitro assay of the antimicrobial activity of kephir against bacterial and fungal strains.	Chifiriuc MC, Cioaca AB, Lazar V	Anaerobe	10.1016/j.anaerobe.2011.04.020	2011	*
Pathogenicity	Biocide activity of microfiber mops with and without silver after contamination.	Lorenzi SD, Romanini L, Finzi G, Salvatorelli G	Braz J Infect Dis	10.1016/s1413-8670(11)70175-1	2011	*
Metabolism	Optimization of antibacterial activity of Perilla frutescens var. acuta leaf against Staphylococcus aureus using evolutionary operation factorial design technique.	Kim DH, Kim YC, Choi UK	Int J Mol Sci	10.3390/ijms12042395	2011	*
Metabolism	One-pot fabrication and antimicrobial properties of novel PET nonwoven fabrics.	Lin S, Wang Z, Qi JC, Wu JH, Tian T, Hou LL, Hao LM, Yang JQ	Biomed Mater	10.1088/1748-6041/6/4/045009	2011	*
Pathogenicity	Antibacterial activity of selected ethnomedicinal plants from South India.	Raja RD, Jeeva S, Prakash JW, Antonisamy JM, Irudayaraj V	Asian Pac J Trop Med	10.1016/S1995-7645(11)60107-7	2011	*
Enzymology	Antimicrobial antioxidant daucane sesquiterpenes from Ferula hermonis Boiss.	Ibraheim ZZ, Abdel-Mageed WM, Dai H, Guo H, Zhang L, Jaspars M	Phytother Res	10.1002/ptr.3609	2011	*
Pathogenicity	Novel hydrogel particles and their IPN films as drug delivery systems with antibacterial properties.	Silan C, Akcali A, Otkun MT, Ozbey N, Butun S, Ozay O, Sahiner N	Colloids Surf B Biointerfaces	10.1016/j.colsurfb.2011.09.024	2011	*
Enzymology	Impact of cleaning regimens in silver-impregnated and hydrogen peroxide lens cases.	Wu YT, Zhu H, Willcox M, Stapleton F	Eye Contact Lens	10.1097/ICL.0b013e318233c901	2011	*
Enzymology	Antibacterial benzofuran neolignans and benzophenanthridine alkaloids from the roots of Zanthoxylum capense.	Luo X, Pedro L, Milic V, Mulhovo S, Duarte A, Duarte N, Ferreira MJ	Planta Med	10.1055/s-0031-1280289	2011	*
Pathogenicity	High hydrostatic pressure treatment for the inactivation of Staphylococcus aureus in human blood plasma.	Rivalain N, Roquain J, Boiron JM, Maurel JP, Largeteau A, Ivanovic Z, Demazeau G	N Biotechnol	10.1016/j.nbt.2011.10.003	2011	*
Pathogenicity	Disinfection of bacterially contaminated hydrophilic PVS impression materials.	Estafanous EW, Palenik CJ, Platt JA	J Prosthodont	10.1111/j.1532-849X.2011.00788.x	2011	*
Pathogenicity	Contact lens disinfecting solutions antibacterial efficacy: comparison between clinical isolates and the standard ISO ATCC strains of Pseudomonas aeruginosa and Staphylococcus aureus.	Mohammadinia M, Rahmani S, Eslami G, Ghassemi-Broumand M, Aghazadh Amiri M, Aghaie G, Tabatabaee SM, Taheri S, Behgozin A	Eye (Lond)	10.1038/eye.2011.284	2011	*
Pathogenicity	An in vitro comparison of two silver-containing antimicrobial wound dressings .	Hooper SJ, Williams DW, Thomas DW, Hill KE, Percival SL	Ostomy Wound Manage		2012	*
Stress	Multiplex reverse transcription polymerase chain reaction to study the expression of virulence and stress response genes in Staphylococcus aureus.	Shrihari RY, Singh NP	J Food Sci	10.1111/j.1750-3841.2011.02542.x	2012	*
Enzymology	Comparative activity of pradofloxacin and marbofloxacin against coagulase-positive staphylococci in a pharmacokinetic-pharmacodynamic model based on canine pharmacokinetics.	Korber-Irrgang B, Wetzstein HG, Bagel-Trah S, Hafner D, Kresken M	J Vet Pharmacol Ther	10.1111/j.1365-2885.2011.01361.x	2012	*
Pathogenicity	Synthesis, structure and antibacterial evaluation of some N-substituted 3-amino-5-hydroxy-4-phenyl-1H-pyrazole-1-carboxamides.	Pitucha M, Kosikowska U, Urszula L, Malm A	Med Chem	10.2174/157340611797928433	2011	*
Pathogenicity	Semisynthesis and antimicrobial activity of novel guttiferone-A derivatives.	Dias KS, Januario JP, D' Dego JL, Dias AL, dos Santos MH, Camps I, Coelho LF, Viegas C Jr	Bioorg Med Chem	10.1016/j.bmc.2012.02.023	2012	*
Metabolism	Attenuated virulence and biofilm formation in Staphylococcus aureus following sublethal exposure to triclosan.	Latimer J, Forbes S, McBain AJ	Antimicrob Agents Chemother	10.1128/AAC.05904-11	2012	*
Pathogenicity	Influence of Nigella sativa fixed oil on some blood parameters and histopathology of skin in staphylococcal-infected BALB/c mice.	Abu-Al-Basal MA	Pak J Biol Sci	10.3923/pjbs.2011.1038.1046	2011	*
Pathogenicity	Chemical composition and antimicrobial activity of Phyllanthus muellerianus (Kuntze) Excel essential oil.	Brusotti G, Cesari I, Gilardoni G, Tosi S, Grisoli P, Picco AM, Caccialanza G	J Ethnopharmacol	10.1016/j.jep.2012.05.032	2012	*
Pathogenicity	In vivo evaluation of the persistant and residual antimicrobial properties of three hand-scrub and hand-rub regimes in a simulated surgical environment.	Beausoleil CM, Paulson DS, Bogert A, Lewis GS	J Hosp Infect	10.1016/j.jhin.2012.05.003	2012	*
Pathogenicity	Bacterial adhesion to unworn and worn silicone hydrogel lenses.	Vijay AK, Zhu H, Ozkan J, Wu D, Masoudi S, Bandara R, Borazjani RN, Willcox MD	Optom Vis Sci	10.1097/OPX.0b013e318264f4dc	2012	*
Enzymology	An ent-kaurane-type diterpene in Croton antisyphiliticus mart.	Pereira S, Taleb-Contini S, Coppede J, Pereira P, Bertoni B, Franca S, Pereira AM	Molecules	10.3390/molecules17088851	2012	*
Pathogenicity	Hydroxyapatites and europium(III) doped hydroxyapatites as a carrier of silver nanoparticles and their antimicrobial activity.	Wiglusz RJ, Kedziora A, Lukowiak A, Doroszkiewicz W, Strek W	J Biomed Nanotechnol	10.1166/jbn.2012.1424	2012	*
Pathogenicity	An antimicrobial evaluation of plants used for the treatment of respiratory infections in rural Maputaland, KwaZulu-Natal, South Africa.	York T, van Vuuren SF, de Wet H	J Ethnopharmacol	10.1016/j.jep.2012.08.038	2012	*
Pathogenicity	Antimicrobial effects of ozonated water on the sanitization of dental instruments contaminated with E. coli, S. aureus, C. albicans, or the spores of B. atrophaeus.	Cesar J, Sumita TC, Junqueira JC, Jorge AO, do Rego MA	J Infect Public Health	10.1016/j.jiph.2011.12.007	2012	*
Biotechnology	Impact of food-related environmental factors on the adherence and biofilm formation of natural Staphylococcus aureus isolates.	Vazquez-Sanchez D, Habimana O, Holck A	Curr Microbiol	10.1007/s00284-012-0247-8	2012	*
Pathogenicity	Synthesis and anti-staphylococcal activity of new 4-diazopyrazole derivatives.	Raimondi MV, Maggio B, Raffa D, Plescia F, Cascioferro S, Cancemi G, Schillaci D, Cusimano MG, Vitale M, Daidone G	Eur J Med Chem	10.1016/j.ejmech.2012.09.041	2012	*
Pathogenicity	Novel dibenzo[b,e]oxepinones from the freshwater-derived fungus Chaetomium sp. YMF 1.02105.	Shen KZ, Gao S, Gao YX, Wang AR, Xu YB, Sun R, Hu PG, Yang GF, Li AJ, Zhong D, Liu HY, Dong JY	Planta Med	10.1055/s-0032-1327828	2012	*
Pathogenicity	Antimicrobial activity of blended essential oil preparation.	Tadtong S, Suppawat S, Tintawee A, Saramas P, Jareonvong S, Hongratanaworakit T	Nat Prod Commun		2012	*
Biotechnology	Rosmarinus officinalis L. essential oil and its majority compound 1,8-cineole at sublethal amounts induce no direct and cross protection in Staphylococcus aureus ATCC 6538.	Gomes Neto NJ, Luz Ida S, Tavares AG, Honorio VG, Magnani M, de Souza EL	Foodborne Pathog Dis	10.1089/fpd.2012.1258	2012	*
Pathogenicity	Antimicrobial N-halamine modified chitosan films.	Li R, Hu P, Ren X, Worley SD, Huang TS	Carbohydr Polym	10.1016/j.carbpol.2012.08.115	2012	*
Phylogeny	Purification and biochemical characterization of a highly thermostable bacteriocin isolated from Brevibacillus brevis strain GM100.	Ghadbane M, Harzallah D, Laribi AI, Jaouadi B, Belhadj H	Biosci Biotechnol Biochem	10.1271/bbb.120681	2013	*
Pathogenicity	Efficient synthesis and antimicrobial activity of some novel S-beta-d-glucosides of 5-aryl-1,2,4-triazole-3-thiones derivatives.	Ji D, Lu J, Lu B, Xin C, Mu J, Li J, Peng C, Bao X	Bioorg Med Chem Lett	10.1016/j.bmcl.2013.02.038	2013	*
Pathogenicity	Antimicrobial potential of Ricinus communis leaf extracts in different solvents against pathogenic bacterial and fungal strains.	Naz R, Bano A	Asian Pac J Trop Biomed	10.1016/S2221-1691(13)60004-0	2012	*
Pathogenicity	Physicochemical properties and antimicrobial activity of Roselle (Hibiscus sabdariffa L.).	Jung E, Kim Y, Joo N	J Sci Food Agric	10.1002/jsfa.6256	2013	*
Enzymology	Monoterpenes with antibacterial activities from a Cameroonian medicinal plant Canthium Multiflorum (Rubiaceae).	Kouam SF, Ngouonpe AW, Bullach A, Lamshoft M, Kuigoua GM, Spiteller M	Fitoterapia	10.1016/j.fitote.2013.08.025	2013	*
Pathogenicity	Preparation, characterization and antimicrobial study of a hydrogel (soft contact lens) material impregnated with silver nanoparticles.	Fazly Bazzaz BS, Khameneh B, Jalili-Behabadi MM, Malaekeh-Nikouei B, Mohajeri SA	Cont Lens Anterior Eye	10.1016/j.clae.2013.09.008	2013	*
Pathogenicity	Silver-doped manganese dioxide and trioxide nanoparticles inhibit both gram positive and gram negative pathogenic bacteria.	Kunkalekar RK, Prabhu MS, Naik MM, Salker AV	Colloids Surf B Biointerfaces	10.1016/j.colsurfb.2013.09.036	2013	*
Pathogenicity	Antibacterial activity of gemini quaternary ammonium salts.	Oblak E, Piecuch A, Guz-Regner K, Dworniczek E	FEMS Microbiol Lett	10.1111/1574-6968.12331	2013	*
Metabolism	Taguchi's experimental design for optimizing the production of novel thermostable polypeptide antibiotic from Geobacillus pallidus SAT4.	Muhammad SA, Ahmed S, Ismail T, Hameed A	Pak J Pharm Sci		2014	*
Pathogenicity	[Use of the materials based on partially reduced graphene-oxide with silver nanoparticle as bacteriostatic and bactericidal agent].	Kedziora A, Gerasymchuk Y, Sroka E, Bugla-Ploskonska G, Doroszkiewicz W, Rybak Z, Hreniak DC, Wilgusz R, Strek WA	Polim Med		2013	*
Metabolism	Ovocalyxin-36 is a pattern recognition protein in chicken eggshell membranes.	Cordeiro CM, Esmaili H, Ansah G, Hincke MT	PLoS One	10.1371/journal.pone.0084112	2013	*
Metabolism	Differences in metabolic profiles of planktonic and biofilm cells in Staphylococcus aureus - (1)H Nuclear Magnetic Resonance search for candidate biomarkers.	Junka AF, Deja S, Smutnicka D, Szymczyk P, Ziolkowski G, Bartoszewicz M, Mlynarz P	Acta Biochim Pol	2013_701-706	2013	*
Pathogenicity	Preparation and evaluation of periodontal films based on polyelectrolyte complex formation.	Kassem AA, Ismail FA, Naggar VF, Aboulmagd E	Pharm Dev Technol	10.3109/10837450.2013.862262	2014	*
Pathogenicity	[Investigation of antimicrobial and antibiofilm effects of some preservatives used in drugs, cosmetics and food products].	Guven N, Kaynak Onurdag F	Mikrobiyol Bul		2014	*
Pathogenicity	Synthesis of carboxymethyl chitosan and coating on wound dressing gauze for wound healing.	Venkatrajah B, Malathy VV, Elayarajah B, Rajendran R, Rammohan R	Pak J Biol Sci	10.3923/pjbs.2013.1438.1448	2013	*
Pathogenicity	Fast and long-acting antibacterial properties of chitosan-Ag/polyvinylpyrrolidone nanocomposite films.	Wang BL, Liu XS, Ji Y, Ren KF, Ji J	Carbohydr Polym	10.1016/j.carbpol.2012.03.080	2012	*
Pathogenicity	Pilot study on the antibacterial activity of hydrogen peroxide and silver ions in the hospital environment.	De Giglio O, Coretti C, Lovero G, Barbuti G, Caggiano G	Ann Ig	10.7416/ai.2014.1974	2014	*
Pathogenicity	Biochemical and antimicrobial activity of phloretin and its glycosilated derivatives present in apple and kumquat.	Barreca D, Bellocco E, Lagana G, Ginestra G, Bisignano C	Food Chem	10.1016/j.foodchem.2014.03.118	2014	*
Pathogenicity	Comparative study to investigate the effect of meloxicam or minocycline HCl in situ gel system on local treatment of periodontal pockets.	Kassem AA, Ismail FA, Naggar VF, Aboulmagd E	AAPS PharmSciTech	10.1208/s12249-014-0118-7	2014	*
Pathogenicity	Influence of sub-inhibitory antibiotics and flow condition on Staphylococcus aureus ATCC 6538 biofilm development and biofilm growth rate: BioTimer assay as a study model.	Berlutti F, Frioni A, Natalizi T, Pantanella F, Valenti P	J Antibiot (Tokyo)	10.1038/ja.2014.66	2014	*
Enzymology	Molecular characterization of a novel hepcidin (HepcD) from Camelus dromedarius. Synthetic peptide forms exhibit antibacterial activity.	Boumaiza M, Ezzine A, Jaouen M, Sari MA, Marzouki MN	J Pept Sci	10.1002/psc.2644	2014	*
Enzymology	Total phenolic and flavonoid contents, antioxidant and antimicrobial activities of Alnus glutinosa (L.) Gaertn., Alnus incana (L.) Moench and Alnus viridis (Chaix) DC. extracts.	Dahija S, Cakar J, Vidic D, Maksimovic M, Paric A	Nat Prod Res	10.1080/14786419.2014.931390	2014	*
Pathogenicity	Antimicrobial, antioxidant and cytotoxic properties of essential oil from Dictamnus angustifolius.	Sun J, Wang X, Wang P, Li L, Qu W, Liang J	J Ethnopharmacol	10.1016/j.jep.2014.06.055	2014	*
Pathogenicity	Discovery of diethyl 2,5-diaminothiophene-3,4-dicarboxylate derivatives as potent anticancer and antimicrobial agents and screening of anti-diabetic activity: synthesis and in vitro biological evaluation. Part 1.	Bozorov K, Ma HR, Zhao JY, Zhao HQ, Chen H, Bobakulov K, Xin XL, Elmuradov B, Shakhidoyatov K, Aisa HA	Eur J Med Chem	10.1016/j.ejmech.2014.07.065	2014	*
Pathogenicity	In vitro screening antibacterial activity of Bidens pilosa Linne and Annona crassiflora Mart. against oxacillin resistant Staphylococcus aureus (ORSA) from the aerial environment at the dental clinic.	Silva JJ, Cerdeira CD, Chavasco JM, Cintra AB, Silva CB, Mendonca AN, Ishikawa T, Boriollo MF, Chavasco JK	Rev Inst Med Trop Sao Paulo	10.1590/s0036-46652014000400011	2014	*
Pathogenicity	One step poly(rutin) particle preparation as biocolloid and its characterization.	Sahiner N	Mater Sci Eng C Mater Biol Appl	10.1016/j.msec.2014.08.009	2014	*
Pathogenicity	Preservative activity of lavender hydrosols in moisturizing body gels.	Kunicka-Styczynska A, Smigielski K, Prusinowska R, Rajkowska K, Kusmider B, Sikora M	Lett Appl Microbiol	10.1111/lam.12346	2014	*
Enzymology	Antimicrobial activity of methanolic extracts of Sambucus ebulus and Urtica dioica against clinical isolates of methicillin resistant Staphylococcus aureus.	Salehzadeh A, Asadpour L, Naeemi AS, Houshmand E	Afr J Tradit Complement Altern Med	10.4314/ajtcam.v11i5.6	2014	*
Metabolism	Evaluation of resistance development and viability recovery by toxigenic and non-toxigenic Staphylococcus aureus strains after repeated cycles of high hydrostatic pressure.	Baptista I, Queiros RP, Cunha A, Rocha SM, Saraiva JA, Almeida A	Food Microbiol	10.1016/j.fm.2014.09.016	2014	*
Pathogenicity	Antibiotic embedded absorbable prosthesis for prevention of surgical mesh infection: experimental study in rats.	Suarez-Grau JM, Morales-Conde S, Gonzalez Galan V, Martin Cartes JA, Docobo Durantez F, Padillo Ruiz FJ	Hernia	10.1007/s10029-014-1334-5	2014	*
Pathogenicity	One new and nine known flavonoids from Choerospondias axillaries and their in vitro antitumor, anti-hypoxia and antibacterial activities.	Li CW, Cui CB	Molecules	10.3390/molecules191221363	2014	*
Pathogenicity	Evaluation of the antibacterial effects of vancomycin hydrochloride released from agar-gelatin-bioactive glass composites.	Rivadeneira J, Di Virgilio AL, Audisio MC, Boccaccini AR, Gorustovich AA	Biomed Mater	10.1088/1748-6041/10/1/015011	2015	*
Metabolism	The antimicrobial activity of prototype modified honeys that generate reactive oxygen species (ROS) hydrogen peroxide.	Cooke J, Dryden M, Patton T, Brennan J, Barrett J	BMC Res Notes	10.1186/s13104-014-0960-4	2015	*
Pathogenicity	Expression of recombinant Arabian camel lactoferricin-related peptide in Pichia pastoris and its antimicrobial identification.	Chahardooli M, Niazi A, Aram F, Sohrabi SM	J Sci Food Agric	10.1002/jsfa.7125	2015	*
Pathogenicity	Single step natural poly(tannic acid) particle preparation as multitalented biomaterial.	Sahiner N, Sagbas S, Aktas N	Mater Sci Eng C Mater Biol Appl	10.1016/j.msec.2015.01.076	2015	*
Enzymology	Bioactivity and chemical composition of the essential oil from the leaves of Guatteria australis A.St.-Hil.	Siqueira CA, Serain AF, Pascoal AC, Andreazza NL, de Lourenco CC, Ruiz AL, de Carvalho JE, de Souza AC, Mesquita JT, Tempone AG, Salvador MJ	Nat Prod Res	10.1080/14786419.2015.1015017	2015	*
Metabolism	pH-responsive release behavior and anti-bacterial activity of bacterial cellulose-silver nanocomposites.	Shao W, Liu H, Liu X, Sun H, Wang S, Zhang R	Int J Biol Macromol	10.1016/j.ijbiomac.2015.02.048	2015	*
Pathogenicity	Synthesis, characterization and antimicrobial activity of water-soluble silver(i) complexes of metronidazole drug and selected counter-ions.	Kalinowska-Lis U, Felczak A, Checinska L, Zawadzka K, Patyna E, Lisowska K, Ochocki J	Dalton Trans	10.1039/c5dt00403a	2015	*
Pathogenicity	Antibacterial triterpenoids from the bark of Sonneratia alba (Lythraceae).	Harizon, Pujiastuti B, Kurnia D, Sumiarsa D, Shiono Y, Supratman U	Nat Prod Commun		2015	*
Pathogenicity	Enhancing activity of antibiotics against Staphylococcus aureus: Zanthoxylum capense constituents and derivatives.	Cabral V, Luo X, Junqueira E, Costa SS, Mulhovo S, Duarte A, Couto I, Viveiros M, Ferreira MJ	Phytomedicine	10.1016/j.phymed.2015.02.003	2015	*
Enzymology	Kinetics and functional effectiveness of nisin loaded antimicrobial packaging film based on chitosan/poly(vinyl alcohol).	Wang H, Zhang R, Zhang H, Jiang S, Liu H, Sun M, Jiang S	Carbohydr Polym	10.1016/j.carbpol.2015.03.058	2015	*
Pathogenicity	Altered Competitive Fitness, Antimicrobial Susceptibility, and Cellular Morphology in a Triclosan-Induced Small-Colony Variant of Staphylococcus aureus.	Forbes S, Latimer J, Bazaid A, McBain AJ	Antimicrob Agents Chemother	10.1128/AAC.00352-15	2015	*
Phylogeny	Susceptibility of selected strains used for evaluation of biocidal efficiency of disinfectants and antibiotic-resistant strains to didecyldimethylammonium chloride in 2-propanol.	Chojecka A, Wiercinska O, Rohm-Rodowald E, Kanclerski K, Jakimiak B	Med Dosw Mikrobiol		2015	*
Pathogenicity	Assessment of antifouling efficacy of polyhedral oligomeric silsesquioxane based poly (urea-urethane-imide) hybrid membranes.	Ajit Walter P, Muthukumar T, Reddy BS	Lett Appl Microbiol	10.1111/lam.12457	2015	*
Pathogenicity	Alternative treatment of vaginal infections - in vitro antimicrobial and toxic effects of Coriandrum sativum L. and Thymus vulgaris L. essential oils.	Bogavac M, Karaman M, Janjusevic Lj, Sudji J, Radovanovic B, Novakovic Z, Simeunovic J, Bozin B	J Appl Microbiol	10.1111/jam.12883	2015	*
Phylogeny	Diversity, Bacterial Symbionts and Antibacterial Potential of Gut-Associated Fungi Isolated from the Pantala flavescens Larvae in China.	Shao MW, Lu YH, Miao S, Zhang Y, Chen TT, Zhang YL	PLoS One	10.1371/journal.pone.0134542	2015	*
Pathogenicity	Design, synthesis and molecular docking of salicylic acid derivatives containing metronidazole as a new class of antimicrobial agents.	Guo ZH, Yin Y, Wang C, Wang PF, Zhang XT, Wang ZC, Zhu HL	Bioorg Med Chem	10.1016/j.bmc.2015.07.075	2015	*
Pathogenicity	Synthesis, electronic properties, antioxidant and antibacterial activity of some new benzimidazoles.	Mavrova ATs, Yancheva D, Anastassova N, Anichina K, Zvezdanovic J, Djordjevic A, Markovic D, Smelcerovic A	Bioorg Med Chem	10.1016/j.bmc.2015.08.029	2015	*
Pathogenicity	In vitro evaluation of the wound healing activity of Drypetes klainei stem bark extracts.	Brusotti G, Andreola F, Sferrazza G, Grisoli P, Merelli A, Robustelli della Cuna FS, Calleri E, Nicotera G, Pierimarchi P, Serafino A	J Ethnopharmacol	10.1016/j.jep.2015.09.015	2015	*
Enzymology	Microbial spoilage, instability risk of antacid suspension in the presence of commonly used preservative system.	Khan JA, Khan IU, Iqbal Z, Nasir F, Muhammad S, Hannan PA, Ullah I	Pak J Pharm Sci		2015	*
Biotechnology	Antimicrobial activity of silver doped fabrics for the production of hospital uniforms.	Condo C, Messi P, Anacarso I, Sabia C, Iseppi R, Bondi M, de Niederhausern S	New Microbiol	496M817	2015	*
Pathogenicity	Inhibitory Effects of 2,2'-Dipyridyl and 1,2,3,4,6-Penta-O-Galloyl-b-D-Glucopyranose on Biofilm Formation in Contact Lens Cases.	Cho P, Shi GS, Boost M	Invest Ophthalmol Vis Sci	10.1167/iovs.15-17723	2015	*
Pathogenicity	Monomeric and gemini surfactants as antimicrobial agents - influence on environmental and reference strains.	Kozirog A, Brycki B	Acta Biochim Pol	10.18388/abp.2015_1150	2015	*
Pathogenicity	Characterization and Mechanism for the Protection of Photolytic Decomposition of N-Halamine Siloxane Coatings by Titanium Dioxide.	Liu Y, Li J, Li L, McFarland S, Ren X, Acevedo O, Huang TS	ACS Appl Mater Interfaces	10.1021/acsami.5b12601	2016	*
Pathogenicity	Screening of the Enterocin-Encoding Genes and Antimicrobial Activity in Enterococcus Species.	Ogaki MB, Rocha KR, Terra MR, Furlaneto MC, Maia LF	J Microbiol Biotechnol	10.4014/jmb.1509.09020	2016	*
Pathogenicity	Three new cembranoids from the Bornean soft coral Nephthea sp.	Ishii T, Kamada T, Vairappan CS	J Asian Nat Prod Res	10.1080/10286020.2016.1145670	2016	*
Pathogenicity	Facile synthesis of monodisperse of hollow mesoporous SiO2 nanoparticles and in-situ growth of Ag nanoparticles for antibacterial.	Xu P, Liang J, Cao X, Tang J, Gao J, Wang L, Shao W, Gao Q, Teng Z	J Colloid Interface Sci	10.1016/j.jcis.2016.04.009	2016	*
Enzymology	Recovery of Gram-Positive Cocci and Candida albicans from Peroxygen/Silver-Based Disinfectants.	Eissa ME, Nouby AS	Pol J Microbiol	10.5604/17331331.1197271	2016	*
Metabolism	Effects of Fibronectin Coating on Bacterial and Osteoblast Progenitor Cells Adherence in a Co-culture Assay.	Hindie M, Wu D, Anselme K, Gallet O, Di Martino P	Adv Exp Med Biol	10.1007/5584_2016_41	2017	*
Pathogenicity	Potential role of Saudi red propolis in alleviating lung damage induced by methicillin resistant Staphylococcus aureus virulence in rats.	Saddiq AA, Mohamed AM	Pak J Pharm Sci		2016	*
Pathogenicity	A comparison of Staphylococcus aureus biofilm formation on cobalt-chrome and titanium-alloy spinal implants.	Patel SS, Aruni W, Inceoglu S, Akpolat YT, Botimer GD, Cheng WK, Danisa OA	J Clin Neurosci	10.1016/j.jocn.2016.03.013	2016	*
Pathogenicity	A bactericidal calix[4]arene-based nanoconstruct with amplified NO photorelease.	Di Bari I, Picciotto R, Granata G, Blanco AR, Consoli GM, Sortino S	Org Biomol Chem	10.1039/c6ob01305h	2016	*
Pathogenicity	Green synthesis of multifunctional silver and gold nanoparticles from the oriental herbal adaptogen: Siberian ginseng.	Abbai R, Mathiyalagan R, Markus J, Kim YJ, Wang C, Singh P, Ahn S, Farh Mel-A, Yang DC	Int J Nanomedicine	10.2147/IJN.S108549	2016	*
Pathogenicity	Synthesis and biofilm formation reduction of pyrazole-4-carboxamide derivatives in some Staphylococcus aureus strains.	Cascioferro S, Maggio B, Raffa D, Raimondi MV, Cusimano MG, Schillaci D, Manachini B, Plescia F, Daidone G	Eur J Med Chem	10.1016/j.ejmech.2016.07.030	2016	*
Pathogenicity	An integrated study on antimicrobial activity and ecotoxicity of quantum dots and quantum dots coated with the antimicrobial peptide indolicidin.	Galdiero E, Siciliano A, Maselli V, Gesuele R, Guida M, Fulgione D, Galdiero S, Lombardi L, Falanga A	Int J Nanomedicine	10.2147/IJN.S107752	2016	*
Pathogenicity	A bioactivity guided study on the antibacterial activity of Hertia cheirifolia L. extracts.	Majouli K, Hamdi A, Msaada K, Kenani A	Microb Pathog	10.1016/j.micpath.2016.10.015	2016	*
Metabolism	Brevibacillin, a cationic lipopeptide that binds to lipoteichoic acid and subsequently disrupts cytoplasmic membrane of Staphylococcus aureus.	Yang X, Huang E, Yousef AE	Microbiol Res	10.1016/j.micres.2016.11.002	2016	*
Pathogenicity	Chemical composition, antimicrobial, antioxidant and anthocyanin activities of mosses (Cinclidotus fontinaloides (Hedw.) P.Beauv. and Palustriella commutata (Hedw.) Ochyra) gathered from Turkey.	Yayintas OT, Alpaslan D, Karagul Yuceer Y, Yilmaz S, Sahiner N	Nat Prod Res	10.1080/14786419.2016.1277355	2017	*
Pathogenicity	The extent of environmental and body contamination through aerosols by hydro-surgical debridement in the lumbar spine.	Putzer D, Lechner R, Coraca-Huber D, Mayr A, Nogler M, Thaler M	Arch Orthop Trauma Surg	10.1007/s00402-017-2668-0	2017	*
Enzymology	Airborne Pathogens inside Automobiles for Domestic Use: Assessing In-Car Air Decontamination Devices Using Staphylococcus aureus as the Challenge Bacterium.	Sattar SA, Zargar B, Wright KE, Rubino JR, Ijaz MK	Appl Environ Microbiol	10.1128/AEM.00258-17	2017	*
Phylogeny	pH-Dependent Antimicrobial Properties of Copper Oxide Nanoparticles in Staphylococcus aureus.	Hsueh YH, Tsai PH, Lin KS	Int J Mol Sci	10.3390/ijms18040793	2017	*
Genetics	Complete Genome Sequence of the Disinfectant Susceptibility Testing Reference Strain Staphylococcus aureus subsp. aureus ATCC 6538.	Makarova O, Johnston P, Walther B, Rolff J, Roesler U	Genome Announc	10.1128/genomeA.00293-17	2017	*
Pathogenicity	Biosynthesized gold and silver nanoparticles by aqueous fruit extract of Chaenomeles sinensis and screening of their biomedical activities.	Oh KH, Soshnikova V, Markus J, Kim YJ, Lee SC, Singh P, Castro-Aceituno V, Ahn S, Kim DH, Shim YJ, Kim YJ, Yang DC	Artif Cells Nanomed Biotechnol	10.1080/21691401.2017.1332636	2017	*
Pathogenicity	A new diaryl 1, 2-diketone from the heartwood of Dalbergia latifolia.	Liu RH, Wang DQ, Zhang PZ, Shao F, Chen LY, Huang HL, Lin S	Nat Prod Res	10.1080/14786419.2017.1338280	2017	*
Pathogenicity	Self-disinfecting surfaces and activity against Staphyloccocus aureus ATCC 6538 under real-life conditions.	Bruhwasser C, Heinrich H, Lass-Florl C, Mayr A	J Hosp Infect	10.1016/j.jhin.2017.06.022	2017	*
Pathogenicity	Antimicrobial Activity of Selected Polyphenols and Capsaicinoids Identified in Pepper (Capsicum annuum L.) and Their Possible Mode of Interaction.	Mokhtar M, Ginestra G, Youcefi F, Filocamo A, Bisignano C, Riazi A	Curr Microbiol	10.1007/s00284-017-1310-2	2017	*
Pathogenicity	Inhibition of bacterial biofilms by carboxymethyl chitosan combined with silver, zinc and copper salts.	Goncalves RC, da Silva DP, Signini R, Naves PLF	Int J Biol Macromol	10.1016/j.ijbiomac.2017.07.048	2017	*
Enzymology	Thermoactinoamide A, an Antibiotic Lipophilic Cyclopeptide from the Icelandic Thermophilic Bacterium Thermoactinomyces vulgaris.	Teta R, Marteinsson VT, Longeon A, Klonowski AM, Groben R, Bourguet-Kondracki ML, Costantino V, Mangoni A	J Nat Prod	10.1021/acs.jnatprod.7b00560	2017	*
Pathogenicity	Antibacterial, tyrosinase, and DNA photocleavage studies of some triazolylnucleosides.	Kumar S, Sukhvinder, Kumar V, Gupta GK, Beniwal V, Abdmouleh F, Ketata E, El Arbi M	Nucleosides Nucleotides Nucleic Acids	10.1080/15257770.2017.1342830	2017	*
Metabolism	Membrane and genomic DNA dual-targeting of citrus flavonoid naringenin against Staphylococcus aureus.	Wang LH, Wang MS, Zeng XA, Xu XM, Brennan CS	Integr Biol (Camb)	10.1039/c7ib00095b	2017	*
Pathogenicity	Synthesis and Biological Activity of Novel O-Alkyl Derivatives of Naringenin and Their Oximes.	Kozlowska J, Potaniec B, Zarowska B, Aniol M	Molecules	10.3390/molecules22091485	2017	*
Pathogenicity	Plectranthus amboinicus essential oil and carvacrol bioactive against planktonic and biofilm of oxacillin- and vancomycin-resistant Staphylococcus aureus.	Vasconcelos SECB, Melo HM, Cavalcante TTA, Junior FEAC, de Carvalho MG, Menezes FGR, de Sousa OV, Costa RA	BMC Complement Altern Med	10.1186/s12906-017-1968-9	2017	*
Pathogenicity	Green synthesis, biological and spectroscopic study on the interaction of multi-component Mannich bases of imidazo[2,1-b]benzothiazoles with human serum albumin.	Maddili SK, Yandrati LP, Siddam S, Kannekanti VK, Gandham H	J Photochem Photobiol B	10.1016/j.jphotobiol.2017.08.026	2017	*
Pathogenicity	Modification of membrane properties and fatty acids biosynthesis-related genes in Escherichia coli and Staphylococcus aureus: Implications for the antibacterial mechanism of naringenin.	Wang LH, Zeng XA, Wang MS, Brennan CS, Gong D	Biochim Biophys Acta Biomembr	10.1016/j.bbamem.2017.11.007	2017	*
Pathogenicity	Isolation and evaluation of cocktail phages for the control of multidrug-resistant Escherichia coli serotype O104: H4 and E. coli O157: H7 isolates causing diarrhea.	Safwat Mohamed D, Farouk Ahmed E, Mohamed Mahmoud A, Abd El-Baky RM, John J	FEMS Microbiol Lett	10.1093/femsle/fnx275	2018	*
Pathogenicity	Chemical content and antimicrobial properties of three different extracts of Mentha pulegium leaves from Mugla Region, Turkey.	Ceyhan-Guvensen N, Keskin D	J Environ Biol		2016	*
Pathogenicity	Neutralization efficiency of alcohol based products used for rapid hand disinfection	Chojecka A, Tarka P, Kierzkowska A, Nitsch-Osuch A, Kanecki K	Rocz Panstw Zakl Hig		2017	*
Metabolism	Elimination of Isoxazolyl-Penicillins antibiotics in waters by the ligninolytic native Colombian strain Leptosphaerulina sp. considerations on biodegradation process and antimicrobial activity removal.	Copete-Pertuz LS, Placido J, Serna-Galvis EA, Torres-Palma RA, Mora A	Sci Total Environ	10.1016/j.scitotenv.2018.02.244	2018	*
Enzymology	PRODUCTION OF ANTIMICROBIAL PEPTIDES BY EPICOCCUM SP. NFW1: AN ENDOPHYTE OF TAXUS FAUNA.	Jadoon M, Fatima N, Murtaza S, Chang LC, Ali N, Ahmed S	Acta Pol Pharm		2016	*
Pathogenicity	Unprotonated Short-Chain Alkylamines Inhibit Staphylolytic Activity of Lysostaphin in a Wall Teichoic Acid-Dependent Manner.	Wu X, Kwon SJ, Kim D, Zha J, Mora-Pale M, Dordick JS	Appl Environ Microbiol	10.1128/AEM.00693-18	2018	*
Pathogenicity	Sealing effectiveness against Staphylococcus aureus of five different implant-abutment connections.	Discepoli N, Ferrari Cagidiaco E, Landini G, Pallecchi L, Garcia-Godoy F, Ferrari M	Am J Dent		2018	*
Pathogenicity	The alpha-Cyclodextrin/Moringin Complex: A New Promising Antimicrobial Agent against Staphylococcus aureus.	Romeo L, Lanza Cariccio V, Iori R, Rollin P, Bramanti P, Mazzon E	Molecules	10.3390/molecules23092097	2018	*
Pathogenicity	New phenoxazinone-related alkaloids from strain Streptomyces sp. KIB-H1318.	Yang FX, Hou GX, Luo J, Yang J, Yan Y, Huang SX	J Antibiot (Tokyo)	10.1038/s41429-018-0099-y	2018	*
Enzymology	Flexible Peptide Linkers Enhance the Antimicrobial Activity of Surface-Immobilized Bacteriolytic Enzymes.	Wu X, Fraser K, Zha J, Dordick JS	ACS Appl Mater Interfaces	10.1021/acsami.8b14411	2018	*
Pathogenicity	Antimicrobial activity of spices essential oils and its effectiveness on mature biofilms of human pathogens.	Condo C, Anacarso I, Sabia C, Iseppi R, Anfelli I, Forti L, de Niederhausern S, Bondi M, Messi P	Nat Prod Res	10.1080/14786419.2018.1490904	2018	*
Pathogenicity	Physiochemical characterization, antioxidative, anticancer cells proliferation and food pathogens antibacterial activity of chitosan nanoparticles loaded with Cyperus articulatus rhizome essential oils.	Kavaz D, Idris M, Onyebuchi C	Int J Biol Macromol	10.1016/j.ijbiomac.2018.11.177	2018	*
Enzymology	Chemical Constituents of the Marine-Derived Fungus Aspergillus sp. SCS-KFD66.	An CL, Kong FD, Ma QY, Xie QY, Yuan JZ, Zhou LM, Dai HF, Yu ZF, Zhao YX	Mar Drugs	10.3390/md16120468	2018	*
Pathogenicity	Multicomponent Approach to a Library of N-Substituted gamma-Lactams.	Suc Sajko J, Ljoljic Bilic V, Kosalec I, Jeric I	ACS Comb Sci	10.1021/acscombsci.8b00147	2018	*
Biotechnology	[Development of biotechnology of fermented milk product with Lactobacillus reuteri LR1 and the evaluation of its functional property in experiment in vitro and in vivo].	Semenikhina VF, Rozhkova IV, Begunova AV, Fedorova TV, Shirshova TI	Vopr Pitan	10.24411/0042-8833-2018-10053	2018	*
Enzymology	Bioactive cytosporone derivatives isolated from the mangrove-derived fungus Dothiorella sp. ML002.	Zheng CJ, Huang GL, Liao HX, Mei RQ, Luo YP, Chen GY, Zhang QY	Bioorg Chem	10.1016/j.bioorg.2019.01.015	2019	*
Pathogenicity	In vitro antimicrobial efficacy of laser exposed chlorpromazine against Gram-positive bacteria in planktonic and biofilm growth state.	Tozar T, Nastasa V, Stoicu A, Chifiriuc MC, Popa M, Kamerzan C, Pascu ML	Microb Pathog	10.1016/j.micpath.2019.02.012	2019	*
Pathogenicity	2,6-Disubstituted imidazo[2,1-b][1,3,4]thiadiazole derivatives as potent staphylococcal biofilm inhibitors.	Cascioferro S, Parrino B, Petri GL, Cusimano MG, Schillaci D, Di Sarno V, Musella S, Giovannetti E, Cirrincione G, Diana P	Eur J Med Chem	10.1016/j.ejmech.2019.02.007	2019	*
Pathogenicity	Two new compounds from the heartwood of Dalbergia melanoxylon.	Lin S, Liu RH, Ma GQ, Mei DY, Shao F, Chen LY	Nat Prod Res	10.1080/14786419.2019.1591397	2019	*
Pathogenicity	Colorimetric microdilution assay: Validation of a standard method for determination of MIC, IC50%, and IC90% of antimicrobial compounds.	Veiga A, Toledo MDGT, Rossa LS, Mengarda M, Stofella NCF, Oliveira LJ, Goncalves AG, Murakami FS	J Microbiol Methods	10.1016/j.mimet.2019.05.003	2019	*
Pathogenicity	Peppermint Essential Oil-Doped Hydroxyapatite Nanoparticles with Antimicrobial Properties.	Badea ML, Iconaru SL, Groza A, Chifiriuc MC, Beuran M, Predoi D	Molecules	10.3390/molecules24112169	2019	*
Enzymology	The Purification, Characterization, and Biological Activity of New Polyketides from Mangrove-Derived Endophytic Fungus Epicoccum nigrum SCNU-F0002.	Yan Z, Wen S, Ding M, Guo H, Huang C, Zhu X, Huang J, She Z, Long Y	Mar Drugs	10.3390/md17070414	2019	*
Pathogenicity	Susceptibility of livestock-associated methicillin-resistant Staphylococcus aureus (LA-MRSA) to chlorhexidine digluconate, octenidine dihydrochloride, polyhexanide, PVP-iodine and triclosan in comparison to hospital-acquired MRSA (HA-MRSA) and community-aquired MRSA (CA-MRSA): a standardized comparison.	Dittmann K, Schmidt T, Muller G, Cuny C, Holtfreter S, Troitzsch D, Pfaff P, Hubner NO	Antimicrob Resist Infect Control	10.1186/s13756-019-0580-9	2019	*
Phylogeny	Isolation and identification of new antibacterial compounds from Bacillus pumilus.	Chu J, Wang Y, Zhao B, Zhang XM, Liu K, Mao L, Kalamiyets E	Appl Microbiol Biotechnol	10.1007/s00253-019-10083-y	2019	*
Pathogenicity	Nitrogen and Sulfur Doped Carbon Dots from Amino Acids for Potential Biomedical Applications.	Sahiner N, Suner SS, Sahiner M, Silan C	J Fluoresc	10.1007/s10895-019-02431-y	2019	*
Metabolism	Destruction of the cell membrane and inhibition of cell phosphatidic acid biosynthesis in Staphylococcus aureus: an explanation for the antibacterial mechanism of morusin.	Pang D, Liao S, Wang W, Mu L, Li E, Shen W, Liu F, Zou Y	Food Funct	10.1039/c9fo01233h	2019	*
Pathogenicity	A New Type of Anatolian Propolis: Evaluation of Its Chemical Composition, Activity Profile and Botanical Origin.	Tugba Degirmencioglu H, Guzelmeric E, Yuksel PI, Kirmizibekmez H, Deniz I, Yesilada E	Chem Biodivers	10.1002/cbdv.201900492	2019	*
Pathogenicity	Antilisterial and physical properties of polysaccharide-collagen films embedded with cell-free supernatant of Lactococcus lactis.	Ma D, Jiang Y, Ahmed S, Qin W, Liu Y	Int J Biol Macromol	10.1016/j.ijbiomac.2019.09.195	2019	*
Pathogenicity	Synthesis and Biological Evaluation of Novel Aminochalcones as Potential Anticancer and Antimicrobial Agents.	Kozlowska J, Potaniec B, Baczynska D, Zarowska B, Aniol M	Molecules	10.3390/molecules24224129	2019	*
Pathogenicity	The effect of sophorolipids against microbial biofilms on medical-grade silicone.	Ceresa C, Fracchia L, Williams M, Banat IM, Diaz De Rienzo MA	J Biotechnol	10.1016/j.jbiotec.2019.12.019	2019	*
Pathogenicity	Antibacterial and photocatalytic activities of 5-nitroindole capped bimetal nanoparticles against multidrug resistant bacteria.	Manoharan RK, Mahalingam S, Gangadaran P, Ahn YH	Colloids Surf B Biointerfaces	10.1016/j.colsurfb.2020.110825	2020	*
Pathogenicity	Imaging studies of bacterial biofilms on cochlear implants-Bioactive glass (BAG) inhibits mature biofilm.	Kirchhoff L, Arweiler-Harbeck D, Arnolds J, Hussain T, Hansen S, Bertram R, Buer J, Lang S, Steinmann J, Hoing B	PLoS One	10.1371/journal.pone.0229198	2020	*
Enzymology	Purification and characterization of seven bioactive compounds from the newly isolated Streptomyces cavourensis TN638 strain via solid-state fermentation.	Kaaniche F, Hamed A, Elleuch L, Chakchouk-Mtibaa A, Smaoui S, Karray-Rebai I, Koubaa I, Arcile G, Allouche N, Mellouli L	Microb Pathog	10.1016/j.micpath.2020.104106	2020	*
Pathogenicity	Production of Mannosylerythritol Lipids (MELs) to be Used as Antimicrobial Agents Against S. aureus ATCC 6538.	Ceresa C, Hutton S, Lajarin-Cuesta M, Heaton R, Hargreaves I, Fracchia L, De Rienzo MAD	Curr Microbiol	10.1007/s00284-020-01927-2	2020	*
Metabolism	Evaluation of antibacterial properties of lactic acid bacteria from traditionally and industrially produced fermented sausages from Germany.	Bungenstock L, Abdulmawjood A, Reich F	PLoS One	10.1371/journal.pone.0230345	2020	*
Pathogenicity	Antibacterial and Antibiofilm Activity of Biosynthesized Silver Nanoparticles Coated With Exopolysaccharides Obtained From Rhodotorula mucilaginosa.	Vazquez-Rodriguez A, Vasto-Anzaldo XG, Leon-Buitimea A, Zarate X, Morones-Ramirez JR	IEEE Trans Nanobioscience	10.1109/TNB.2020.2985101	2020	*
Pathogenicity	Bactericidal and antifouling electrospun PVA nanofibers modified with a quaternary ammonium salt and zwitterionic sulfopropylbetaine.	Zhang T, Gu J, Liu X, Wei D, Zhou H, Xiao H, Zhang Z, Yu H, Chen S	Mater Sci Eng C Mater Biol Appl	10.1016/j.msec.2020.110855	2020	*
Biotechnology	Correlation between chemical composition and antimicrobial properties of essential oils against most common food pathogens and spoilers: In-vitro efficacy and predictive modelling.	Bagheri L, Khodaei N, Salmieri S, Karboune S, Lacroix M	Microb Pathog	10.1016/j.micpath.2020.104212	2020	*
Pathogenicity	Silver nanocomposites based on the bacterial fucose-rich polysaccharide secreted by Enterobacter A47 for wound dressing applications: Synthesis, characterization and in vitro bioactivity.	Concordio-Reis P, Pereira CV, Batista MP, Sevrin C, Grandfils C, Marques AC, Fortunato E, Gaspar FB, Matias AA, Freitas F, Reis MAM	Int J Biol Macromol	10.1016/j.ijbiomac.2020.07.072	2020	*
Pathogenicity	Synthesis of novel multi-hydroxyl N-halamine precursors based on barbituric acid and their applications in antibacterial poly(ethylene terephthalate) (PET) materials.	Wu K, Li J, Chen X, Yao J, Shao Z	J Mater Chem B	10.1039/d0tb01497d	2020	*
Pathogenicity	Methylene Blue Is an Effective Disclosing Agent for Identifying Bacterial Biofilms on Orthopaedic Implants.	Shaw JD, Brodke DS, Williams DL, Ashton NN	J Bone Joint Surg Am	10.2106/JBJS.20.00091	2020	*
Metabolism	Bacterial Biotransformation and Anticancer Activities of Betulin against A549, HepG2 and 5RP7 Cancer Cell Lines.	Kiran I, Ciftci GA, Eklioglu OA, Akkaya SGK	Anticancer Agents Med Chem	10.2174/1871520620666201029102400	2021	*
Phylogeny	Antimicrobial Potential of Streptomyces ansochromogenes (PB3) Isolated From a Plant Native to the Amazon Against Pseudomonas aeruginosa.	Amorim EADF, Castro EJM, da Souza SV, Alves MS, Dias LRL, Melo MHF, da Silva IMA, Villis PCM, Bonfim MRQ, Falcai A, Silva MRC, Monteiro-Neto V, Alianca A, da Silva LCN, de Miranda RCM	Front Microbiol	10.3389/fmicb.2020.574693	2020	*
Pathogenicity	Novel porous chitosan/N-halamine structure with efficient antibacterial and hemostatic properties.	Zheng Y, Pan N, Liu Y, Ren X	Carbohydr Polym	10.1016/j.carbpol.2020.117205	2020	*
Pathogenicity	Thiazole Analogues of the Marine Alkaloid Nortopsentin as Inhibitors of Bacterial Biofilm Formation.	Carbone A, Cascioferro S, Parrino B, Carbone D, Pecoraro C, Schillaci D, Cusimano MG, Cirrincione G, Diana P	Molecules	10.3390/molecules26010081	2020	*
Pathogenicity	Smart Textiles with Self-Disinfection and Photothermochromic Effects.	Nie X, Wu S, Huang F, Wang Q, Wei Q	ACS Appl Mater Interfaces	10.1021/acsami.0c18474	2021	*
Pathogenicity	Semi-synthesis of N-alkyl-kappa-carrageenan derivatives and evaluation of their antibacterial activity.	Junior EH, Goncalves AG, Noseda MD, Duarte MER, Murakami FS, Ducatti DRB	Carbohydr Res	10.1016/j.carres.2021.108234	2021	*
Pathogenicity	Component Composition and Antimicrobial Activity of CO2 Extract of Portulaca oleracea, Growing in the Territory of Kazakhstan.	Tleubayeva MI, Datkhayev UM, Alimzhanova M, Ishmuratova MY, Korotetskaya NV, Abdullabekova RM, Flisyuk EV, Gemejiyeva NG	ScientificWorldJournal	10.1155/2021/5434525	2021	*
Enzymology	Degradation of Staphylococcus aureus Biofilm Using Hydrolytic Enzymes Produced by Amazonian Endophytic Fungi.	Matias RR, Sepulveda AMG, Batista BN, de Lucena JMVM, Albuquerque PM	Appl Biochem Biotechnol	10.1007/s12010-021-03542-8	2021	*
Pathogenicity	PHMB-loaded PDMS and its antimicrobial properties for biomedical applications.	Montemezzo M, Ferrari MD, Kerstner E, Santos VD, Victorazzi Lain V, Wollheim C, Frozza CODS, Roesch-Ely M, Baldo G, Brandalise RN	J Biomater Appl	10.1177/08853282211011921	2021	*
Cultivation	An Ecological and Miniaturized Biological Method for the Analysis of Daptomycin Potency.	Richardi JF, Kogawa AC, Belavenuto EGT, Chorilli M, Salgado HRN	J AOAC Int	10.1093/jaoacint/qsaa112	2021	*
Pathogenicity	Phytochemical Characterization of Olea europea Leaf Extracts and Assessment of Their Anti-Microbial and Anti-HSV-1 Activity.	Ben-Amor I, Musarra-Pizzo M, Smeriglio A, D'Arrigo M, Pennisi R, Attia H, Gargouri B, Trombetta D, Mandalari G, Sciortino MT	Viruses	10.3390/v13061085	2021	*
Pathogenicity	Synthesis, Molecular Docking, and Biofilm Formation Inhibitory Activity of Bis(Indolyl)Pyridines Analogues of the Marine Alkaloid Nortopsentin.	Abo-Salem HM, Abd El Salam HA, Abdel-Aziem AM, Abdel-Aziz MS, El-Sawy ER	Molecules	10.3390/molecules26144112	2021	*
Enzymology	Chemical Profile, Antioxidant Capacity, and Antimicrobial Activity of Essential Oils Extracted from Three Different Varieties (Moldoveanca 4, Vis Magic 10, and Alba 7) of Lavandula angustifolia.	Bogdan MA, Bungau S, Tit DM, Zaha DC, Nechifor AC, Behl T, Chambre D, Lupitu AI, Copolovici L, Copolovici DM	Molecules	10.3390/molecules26144381	2021	*
Pathogenicity	The Digestibility of Hibiscus sabdariffa L. Polyphenols Using an In Vitro Human Digestion Model and Evaluation of Their Antimicrobial Activity.	Majdoub YOE, Ginestra G, Mandalari G, Dugo P, Mondello L, Cacciola F	Nutrients	10.3390/nu13072360	2021	*
Pathogenicity	Chemical composition of essential oils of eight Tunisian Eucalyptus species and their antibacterial activity against strains responsible for otitis.	Ameur E, Sarra M, Yosra D, Mariem K, Nabil A, Lynen F, Larbi KM	BMC Complement Med Ther	10.1186/s12906-021-03379-y	2021	*
Pathogenicity	Production of a Class IIb Bacteriocin with Broad-spectrum Antimicrobial Activity in Lactiplantibacillus plantarum RUB1.	Wu A, Fu Y, Kong L, Shen Q, Liu M, Zeng X, Wu Z, Guo Y, Pan D	Probiotics Antimicrob Proteins	10.1007/s12602-021-09815-2	2021	*
Phylogeny	Evaluation of antimicrobial and antiproliferative activities of Actinobacteria isolated from the saline lagoons of northwestern Peru.	Flores Clavo R, Ruiz Quinones N, Hernandez-Tasco AJ, Jose Salvador M, Tasca Gois Ruiz AL, de Oliveira Braga LE, Henrique Costa J, Pacheco Fill T, Arce Gil ZL, Serquen Lopez LM, Fantinatti Garboggini F	PLoS One	10.1371/journal.pone.0240946	2021	*
Pathogenicity	Antimicrobial Activity of Gemini Surfactants with Ether Group in the Spacer Part.	Brycki BE, Szulc A, Kowalczyk I, Kozirog A, Sobolewska E	Molecules	10.3390/molecules26195759	2021	*
Enzymology	Antibacterial pathway of cefquinome against Staphylococcus aureus based on label-free quantitative proteomics analysis.	Gao L, Zhu H, Chen Y, Yang Y	J Microbiol	10.1007/s12275-021-1201-x	2021	*
Pathogenicity	Cytotoxic Indole-Diterpenoids from the Marine-Derived Fungus Penicillium sp. KFD28.	Dai LT, Yang L, Kong FD, Ma QY, Xie QY, Dai HF, Yu ZF, Zhao YX	Mar Drugs	10.3390/md19110613	2021	*
Pathogenicity	Green synthesis of silver nanoparticles using sodium alginate and tannic acid: characterization and anti-S. aureus activity.	Tian S, Hu Y, Chen X, Liu C, Xue Y, Han B	Int J Biol Macromol	10.1016/j.ijbiomac.2021.12.031	2021	*
Pathogenicity	Efficacy of various decontamination methods and sterilization on contaminated and inoculated diamond-coated burs.	Wirth NM, Henrichs LE, Savett D, Lien W, Crabtree M, Vandewalle KS	Gen Dent		2022	*
Pathogenicity	Gamma irradiation effectuality on the antibacterial and bioactivity behavior of multicomponent borate glasses against methicillin-resistant Staphylococcus aureus (MRSA).	Abd-Allah WM, Fathy RM	J Biol Inorg Chem	10.1007/s00775-021-01918-z	2022	*
Pathogenicity	Serum Stable and Low Hemolytic Temporin-SHa Peptide Analogs Disrupt Cell Membrane of Methicillin-Resistant Staphylococcus aureus (MRSA).	Maharjan R, Khan AI, Nadeem-Ul-Haque M, Maresca M, Choudhary MI, Shaheen F, Simjee SU	Probiotics Antimicrob Proteins	10.1007/s12602-022-09915-7	2022	*
Pathogenicity	Nanobubble Ozone Stored in Hyaluronic Acid Decorated Liposomes: Antibacterial, Anti-SARS-CoV-2 Effect and Biocompatibility Tests.	Sabanci AU, Erkan Alkan P, Mujde C, Polat HU, Ornek Erguzeloglu C, Bisgin A, Ozakin C, Temel SG	Int J Nanomedicine	10.2147/IJN.S328090	2022	*
Enzymology	Anatomical and Phytochemical Characteristics of Different Parts of Hypericum scabrum L. Extracts, Essential Oils, and Their Antimicrobial Potential.	Ergin KN, Karakaya S, Goger G, Sytar O, Demirci B, Duman H	Molecules	10.3390/molecules27041228	2022	*
Pathogenicity	Synthesis, Characterization, Biological Evaluation and DNA Interaction Studies of 4-Aminophenol Derivatives: Theoretical and Experimental Approach.	Rafique B, Kalsoom S, Sajini AA, Ismail H, Iqbal M	Molecules	10.3390/molecules27041352	2022	*
Phylogeny	Isolation of bacterial consortia with probiotic potential from the rumen of tropical calves.	Rodriguez-Gonzalez S, Gonzalez-Davalos L, Robles-Rodriguez C, Lozano-Flores C, Varela-Echavarria A, Shimada A, Mora-Izaguirre O	J Anim Physiol Anim Nutr (Berl)	10.1111/jpn.13699	2022	*
Pathogenicity	An Experimental Analysis of Five Household Equipment-Based Methods for Decontamination and Reuse of Surgical Masks.	Scaglione E, De Falco G, Mantova G, Caturano V, Stornaiuolo A, D'Anna A, Salvatore P	Int J Environ Res Public Health	10.3390/ijerph19063296	2022	*
Pathogenicity	In vitro antibacterial and cytotoxic effects of Euphorbia grandicornis Blanc chemical constituents.	Kemboi D, Langat MK, Siwe-Noundou X, Krause RWM, Isaacs ML, Tembu VJ	BMC Complement Med Ther	10.1186/s12906-022-03571-8	2022	*
Pathogenicity	Microbial Contamination and Survival Rate on Different Types of Banknotes.	Cozorici D, Maciuca RA, Stancu C, Tihauan BM, Uta RB, Codrea CI, Matache R, Pop CE, Wolff R, Fendrihan S	Int J Environ Res Public Health	10.3390/ijerph19074310	2022	*
Pathogenicity	Antibiotic Isoflavonoids, Anthraquinones, and Pterocarpanoids from Pigeon Pea (Cajanus cajan L.) Seeds against Multidrug-Resistant Staphylococcus aureus.	Balida LAP, Regalado JTA, Teodosio JJR, Dizon KAH, Sun Z, Zhan ZQ, Blancaflor JMD, Sollesta JVN, Villorente ZM, Saludes JP, Dalisay DS	Metabolites	10.3390/metabo12040279	2022	*
Pathogenicity	Novel Graphene Oxide/Quercetin and Graphene Oxide/Juglone Nanostructured Platforms as Effective Drug Delivery Systems with Biomedical Applications.	Croitoru AM, Morosan A, Tihauan B, Oprea O, Motelica L, Trusca R, Nicoara AI, Popescu RC, Savu D, Mihaiescu DE, Ficai A	Nanomaterials (Basel)	10.3390/nano12111943	2022	*

Search for species Staphylococcus aureus in external resources:
SILVA
BRENDA
PANGAEA
StrainInfo
GBIF